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Zusammenfassung
Mehr als 90% der Mortalität durch Brustkrebs wird durch Metastasen verursacht und 
nicht durch den primären Tumor in der Brust [1]. Es ist wichtig, die Mechanismen der 
Metastasenbildung aufzuklären und dadurch Biomarker für metastasierten Brustkrebs zu 
identifizieren, die dabei helfen können, Patienten besser zu behandeln. Krebszellen überleben 
unter Extrembedingungen in der Tumor-Mikroumgebung (TMU), die durch Hypoxie, einen
sauren extrazellulären pH Wert und Nährstoffmangel charakterisiert ist, und sie können in dieser 
feindlichen Umgebung wachsen [2]. Krebszellen kommunizieren kontinuierlich mit der sie 
umgebenden extrazellulären Matrix (EZM) durch Integrine, die dann bei der Metastasenbildung 
mitwirken [3]. Kollagen I (Kol1) Fasern sind eine wesentliche strukturelle Komponente der 
EZM im Brustkrebs [4]. Eine erhöhte Kol1 Faserdichte verursacht den Beginn des 
Tumorwachstums, die Fortschreitung des Krebses und die Metastasenbildung [5]. Sternförmig 
ausgerichtete Kol1 Fasern sind ein prognostischer Marker für die Aggressivität des Tumors. Es 
wurde gezeigt, dass Tumorzellen sich entlang dieser sternförmig ausgerichteten Fasern 
fortbewegen [6]. Wenn ein Tumor wächst, kann es passieren, dass die Gefäßversorgung des 
Tumors vorübergehend nicht mehr mit dem Tumorwachstum mithalten kann und sich dadurch 
hypoxische Regionen im Tumor bilden [7]. Hypoxische Tumor-Milieus sind dafür bekannt, dass 
sie gegen Behandlungen resistent sind und dass sie dem Krebs einen aggressiven Phänotyp 
verleihen [8].
Im Mittelpunkt dieser Doktorarbeit steht das Verstehen der Rolle der Kol1 Fasern, die die 
Hauptkomponente der EZM im Tumor bilden, und ihr Zusammenhang mit der 
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Metastasenbildung, der Hypoxie, dem makromolekularen Transport, der Wasserdiffusion und 
der fraktionalen Anisotropie. Die Untersuchungen in dieser Doktorarbeit wurden mit klinischen 
Brustkrebsproben und menschlichen Brustkrebszellen, die als Xenograft-Tumore in 
immungeschwächten Mäusen wuchsen, durchgeführt. Diese Xenograft-Tumore wurden 
gentechnisch dahingehend verändert, dass sie unter hypoxischen Bedingungen fluoreszieren. Es 
wurde eine multimodale Bildgebung benutzt, bei der optische und kernspintomographische 
Methoden kombiniert wurden.  Kol1 Fasern wurden dabei durch eine mikroskopische Methode, 
die die zweite Oberschwingung der Kol1 Fasern misst, sichtbar gemacht. Dies wurde mit 
optischer Bildgebung zur Detektion von fluoreszierenden, hypoxischen Tumorregionen 
kombiniert. Dies wurde wiederum entweder mit dynamischer, kontrastmittelverstärkter 
Kernspintomographie kombiniert, um die funktionelle Rolle der Kol1 Fasern im 
makromolekularen Transport zu charakterisieren, oder mit Diffusions-Tensor-Bildgebung, um 
die Funktion der Kol1 Fasern während der Wasserdiffusion im Tumor zu beschreiben.
Wir haben beobachtet, dass Kol1 Fasern innerhalb des Tumors heterogen verteilt sind, 
wobei eine geringere Faserdichte in Tumorregionen mit hypoxischen Bedingungen festgestellt 
wurde im Vergleich zu normoxischen Regionen im Tumor (Kapitel 2) [9]. Für diese 
Untersuchungen wurden die oben beschriebenen Brustkrebs-Xenograft-Modelle verwendet. 
Primärtumorproben von Patientinnen mit Metastasen in den Lymphknoten hatten eine wesentlich 
höhere Kol1 Faserdichte als Proben von Patientinnen, deren Krebs sich noch nicht bis zu den 
Lymphknoten ausgebreitet hatte (Kapitel 3) [10]. Wir haben auch die funktionellen Aspekte der 
unterschiedlichen Kol1 Faserausprägungen in normoxischen und hypoxischen Regionen im oben 
beschriebenen MDA-MB-231 Brustkrebs-Xenograft-Modell untersucht (Kapitel 4) [11]. In 
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hypoxischen Regionen mit niedriger Faserdichte herrschte ein geringerer, makromolekularer 
Transport vor, was, im Vergleich mit normoxischen Regionen mit hoher Kol1 Faserdichte in 
diesem Xenograft Modell, durch weniger Dränage und weniger Zufluss von makromolekularem 
Kontrastmittel innerhalb des Tumors nachgewiesen wurde. Diese hypoxischen Regionen waren 
ebenfalls durch eine erniedrigte Wasserdiffusion und geringere Anisotropie gekennzeichnet [11,
12]. Hohe Faserdichten korrelierten mit einer erhöhten Wasserdiffusion und Faser-Anisotropie in 
Brustkrebspräparaten von Patientinnen [12].
Die Studien dieser Doktorarbeit haben dazu beigetragen, strukturelle und funktionelle 
Veränderungen, die im Tumor in Kol1 Fasern unter dem Einfluss hypoxischer Bedingungen 
entstehen, in klinischen Brustkrebspräparaten und in vorklinischen Brusttumor-Xenograft-
Modellen aufzuklären. Diffusions-Tensor-Bildgebung wurde als mögliche, nicht-invasive 
Bildgebungsmethode geprüft, um Kol1 Fasern indirekt, über ihre Auswirkungen auf die 
Wasserdiffusion, zu detektieren. Die Daten, die in dieser Doktorarbeit präsentiert wurden, 
könnten in der Zukunft bei der Behandlungsplanung von Brustkrebspatientinnen und bei der 
Überwachung der Medikamentenverabreichung in diesen Patientinnen helfen.
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Chapter 1 
Introduction
20
The work presented in this thesis represents a culmination of four years of research work 
focused on understanding the role of collagen I (Col1) fibers, a major component of the tumor 
extracellular matrix.  We have investigated the relationship of Col1 fibers with metastasis, 
hypoxia, macromolecular transport, water diffusion and fractional anisotropy using clinical 
breast cancer specimens and human breast cancer xenografts genetically engineered to fluoresce 
under hypoxia.  In the subsequent sections we have provided brief introductory overviews of the 
rationale for our studies, which have been either published or submitted as four separate papers.
The breast cancer epidemic
The incidence of breast cancer has shown a three-fold increase over the past 30 years [1].
Based on forecasted changes in population demographics at the current global cancer rate the 
incidence of breast cancer is expected to show a further two-fold increase by 2030, reaching 
epidemic proportions [1].  While mortality rates are decreasing slightly in Western countries, 
breast cancer continues to have a devastating effect in terms of mortality and quality of life, 
especially in the case of recurrent or metastatic disease.  Local or regional recurrences and 
metastatic disease have an unfavorable prognosis, and distant metastases are mostly treated with 
palliative rather than curative approaches.  The 5-year survival rate of breast cancer patients 
drops from 96% to 75% with regional spread, and to 20% with distant spread [2], with axillary 
lymph node-positive patients more likely to develop distant metastasis.  It is therefore imperative 
to search for new possibilities in the etiology, progression and treatment of breast cancer, and to 
understand causes for recurrence and metastasis.  In 2013, 232,000 female and 2,240 male new 
cases were detected with breast cancer in the USA alone, with 39,620 female and 410 male 
21
deaths (National Cancer Institute – NCI) [3].  The two most common types of breast cancer are 
lobular carcinomas, which arise from the milk-producing lobules and ductal carcinomas, which 
arise from the milk-carrying ducts.  A summary of breast cancer staging based on tumor size and 
lymphatic and metastatic spread is outlined in Table 1 [3].
Table 1: Summary of breast cancer staging
Staging Description
Stage 0 The cancer is confined to its tissue.  Ductal carcinoma in situ (DCIS) – cancer confined to the breast 
ductal lining; lobular carcinoma in situ (LCIS) – cancer confined to the lobules of the breast; Paget 
disease – cancer confined to the nipple.
Stage IA The tumor is 2 cm or smaller and has not spread outside the breast.
Stage IB Cluster of tumor no more than 2 mm is found in the lymph node with either no tumor found in the 
breast or tumor less than 2 cm in the breast.
Stage IIA 1. Cancer is larger than 2 mm and found in 1-3 axillary lymph nodes or lymph nodes near the 
breastbone with either no tumor in the breast or tumor smaller than 2 cm; OR
2. Tumor is larger than 2 cm but smaller than 5 cm and has not spread to the lymph nodes.
Stage IIB 1. Breast tumor is larger than 2 cm but smaller than 5 cm and small clusters of cancer of less than 
2 mm are found in the lymph nodes; OR
2. Breast tumor is larger than 2 cm but smaller than 5 cm with cancer spread to 1-3 axillary lymph 
nodes or to lymph nodes near breastbone; OR
3. Breast tumor is larger than 5 cm and cancer has not spread to the lymph nodes.
Stage IIIA 1. No tumor is found in the breast or the tumor is of any size with 4-9 axillary lymph nodes or 
lymph nodes near the breastbone; OR
2. Tumor is larger than 5 cm and small cluster of cancer less than 2 mm is found in the lymph 
nodes; OR
3. The tumor is larger than 5 cm and cancer has spread to 1-3 axillary lymph nodes or lymph 
nodes near breastbone.
Stage IIIB The cancer can be of any size and has spread to the chest wall and/or breast skin and also may have 
spread either to up to 9 axillary lymph nodes or lymph nodes near breastbone.
Stage IIIC No tumor or breast tumor of any size with cancer spread to the breast skin with swelling and/or 
spread to the chest wall, and has also spread to 10 or more axillary lymph nodes; OR to lymph 
nodes above or below collarbone; OR axillary lymph node and lymph node near breastbone.
Stage IV Cancer has spread to other parts of the body.
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Early detection of breast cancer increases the chances of detecting the primary tumor 
prior to metastatic dissemination.  Detection at later stages increases the incidence of recurrence, 
which is associated with poor prognosis.  Metastasis is a leading cause of mortality from breast 
cancer.  Understanding the mechanisms that contribute to or drive metastatic dissemination in 
breast cancer is of critical importance in reducing mortality from this disease.  In the second
paper (Chapter 3) we have focused on understanding the role of Col1 fibers in the metastatic 
dissemination of breast cancer.  
A typical course of treatment includes surgical removal of the breast tumor, followed in 
many cases by radiation- or chemotherapy or both.  In breast cancers that overexpress estrogen 
receptors (ER), anti-estrogen therapy is commonly given to prevent tumor recurrence from any 
remaining residual cancer cells [4].  Targeted therapy comprises a different group of treatments 
that may be given to treat breast cancer.  Targeted therapy specifically targets cancer cells by 
selectively blocking a pathway or receptor that is exclusively expressed or activated in cancer 
cells, such as for example targeting of the human epidermal growth factor receptor 2 (HER2)
receptor in breast cancer [5].  A subset of breast cancers that do not express ER, progesterone 
receptors (PR) or HER2 are commonly referred to as triple-negative breast cancers.  Triple-
negative breast cancers are the most difficult to treat.  Conventional chemotherapy such as 
treatment with anthracyclines, taxanes, or platinum-based agents, which non-specifically inhibit 
cell growth of fast proliferating cells [6] is the primary option for treating triple-negative and late 
stage breast cancers.  Conventional chemotherapy results in deleterious side effects due to 
normal tissue damage.  Another problem with treating breast cancers is that chemotherapeutic or 
targeted agents are often not effectively delivered within the tumor due to the abnormal and 
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chaotic vasculature frequently found in tumors [7].  Such abnormal vascular and lymphatic 
networks in tumors impose additional physiological abnormalities in the tumor 
microenvironment, such as hypoxia, an acidic extracellular pH (pHe), and an increased 
interstitial pressure [8].  These changes are often observed in addition to metabolic alterations in 
breast tumors such as an altered glucose, glutamine, choline, and glycine metabolism [9-12].
Hypoxia, the tumor microenvironment, the ECM and collagen I
The existence of hypoxia in tumors and its implications for failure of radiation therapy 
was predicted by Thomlinson and Gray in 1955 [13], based on observations that necrosis in 
human lung carcinomas occurred at approximately 150 μm, which is the calculated diffusion 
distance of oxygen from the nearest capillary.  Six decades later, hypoxia and the hypoxia 
inducible factors (HIF-1 and -2) are being associated with the transcriptional activation of an 
ever-increasing number of genes that regulate several phenotypic characteristics of cancer [14].
Tumor hypoxia can be diffusion-limited or chronic, or can arise acutely from vascular collapse 
[15, 16].  Most treatments, especially radiation therapy, result in reoxygenation [17, 18].
HIF-1 is a heterodimeric protein that consists of a constitutively expressed ?-subunit and 
an oxygen-dependent ?-subunit that is rapidly degraded through polyubiquitination and 
proteasomal degradation under well-oxygenated conditions [19].  Under hypoxic conditions, 
HIF-1? or HIF-2? undergo heterodimerization with HIF-1? and bind to hypoxia response 
elements (HRE) to activate the transcription of several target genes [20].  These target genes 
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control angiogenesis, cell survival, resistance to chemo- and radiation therapy, metabolism, pH 
regulation, invasion and metastasis, increased genetic instability, and de-differentiation [14, 21].
The tumor microenvironment is critically important in the evolution of the malignant 
phenotype [22].  Cancer cells have a remarkable ability to adapt to their environment [23]. The 
extracellular matrix (ECM), cancer associated fibroblasts (CAFs), adipocytes, pericytes, multiple 
immune cells such as tumor-associated macrophages (TAMs), and vascular and lymphatic 
endothelial cells (Figure 1) that surround and support cancer cells, comprise the tumor 
microenvironment [24].  Cancer cells’ genomic plasticity and their interaction with the tumor 
microenvironment give rise to several lethal phenotypic traits to survive and adapt to hostile 
physiological environments such as hypoxia, acidic pH, and substrate deprivation [24].  In 
addition, cancer cells have the ability to survive lethal treatments [24]
The tumor microenvironment interacts with cancer cells and plays a dual role by creating 
tumor-promoting and tumor-restricting environments [24, 25].  Cancer cells recruit 
?????????????, CAFs and adipocytes, TAMs, which cause tumor-associated changes in the ECM 
[24, 25].  Unlike normal myofibroblasts in wound healing, in pathology their existence persists 
leading to fibrosis by excessive production of collagen [26].  CAFs support tumor growth by 
secreting vascular endothelial growth factor (VEGF), fibroblast growth factors (FGFs), platelet-
derived growth factor (PDGF), and promoting angiogenesis [27]. Cancer associated adipocytes 
(CAAs) acquire a fibroblast-like shape and have been shown to stimulate cancer cell migration 
[28].  TAMs are recruited in cancer in response to inflammation and promote angiogenesis by 
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secreting VEGF, FGFs, PDGF, and collect in hypoxic regions of the tumor [27].  During 
invasion, cancer cells are embedded within this complex stroma, and both cell-cell and cell-
matrix adhesions by integrins, cadherins, and can regulate tumor dissemination by collective cell 
migration [24, 29] .  Cancer cells secrete degrading enzymes such as cysteine, aspartic and serine 
proteases, and matrix metalloproteinases to degrade and remodel the ECM, which enables their 
invasion into the surrounding tissue [24].
Figure 1: Schematic to show the different components of the tumor microenvironment.  The image of 
collagen 1 fibers overlaid with hypoxic regions was obtained from an MDA-MB-231 tumors expressing 
enhanced green fluorescent protein (EGFP) under control of HREs.  Collagen I fiber images were 
acquired with second harmonic generation (SHG) microscopy.  The 3D display of the tumor is a 
parametric image of extracellular transport of a macromolecular contrast agent.  The vascular and 
lymphatic network image is from http://www.imm.ox.ac.uk/wimm-research/mrc-human-immunology-
unit/david-jackson/Fig3.jpg/image_preview.
From: Stasinopoulos, Penet, Chen, Kakkad, Glunde and Bhujwalla; NMR in Biomedicine, 2011[24]
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Tumors actively secrete proteolytic enzymes that continuously remodel the ECM, which 
is comprised of collagens, glycoproteins and proteoglycans [30, 31].  Lysosomal cathepsins 
proteolytically degrade the ECM both intracellularly following endocytosis of ECM components 
or extracellularly following cathepsin secretion, which has a profound effects on tumor ECM 
components such as fibrillar Col1 [32], laminin [33], and fibronectin [24, 34, 35].
Col1 fibers are a major structural component of the ECM in breast cancer and play an 
important role for drug delivery in tumors [36, 37].  There are more than 20 types of collagen 
proteins, but Col1 is the most abundant collagen in the human body [38].  Col1 fibers belong to 
the fibrillar collagen family and their main role is to provide strength and support to tissues [38].
Col1 fiber synthesis is a versatile multi-step process, which starts inside the cell with the 
formation of the pro-collagen I triple helix from the Col1A1 and Col1A2 genes [39].  Pro-
collagen I is secreted and converted to tropocollagen, which in turn self-assembles and is cross-
linked to form mature Col1 fibers.  The final size of mature Col1 fibers can be up to 500 nm by 1 
cm [40].  Malignant breast cancers are characterized by significantly higher Col1 fiber density 
and altered Col1 fiber architecture [41].  High mammary Col1 density was shown to cause 
mammary tumor initiation, progression and metastasis [41].  Overexpression of integrins such as 
???????????????????????????????????????????????????????????????????????[42].
In the second paper (Chapter 3), we have applied second harmonic generation (SHG) 
microscopy to detect differences in Col1 fibers in hypoxic versus normoxic tumor regions, using 
human breast tumor xenografts stably expressing enhanced green fluorescent protein (EGFP) 
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under the control of HREs in the promoter of VEGF [43].  Hypoxic tumor regions were found to 
contain fewer Col1 fibers than normoxic tumor regions [44].  Magnetic resonance imaging 
(MRI) of the macromolecular contrast agent (MMCA) albumin-GdDTPA can be used to 
characterize the extravascular transport of macromolecules through the ECM of solid tumors in 
vivo [45, 46].  Macromolecular transport can be characterized by quantifying tumor regions, 
from which the MMCA is either draining, or in which it is pooling [45].  With this method, it 
was possible to detect an increased drainage in more invasive breast tumors that had a greater 
capacity to degrade the ECM [46].  In the third paper (Chapter 4), we have related 
macromolecular transport through the ECM in tumors to Col1 fiber volume and distribution in 
these tumors, to characterize the functional impact of Col1 fiber patterns in normoxic and 
hypoxic tumor regions [47].  Finally, we have further sought to expand our understanding of the 
relationship between transport through the ECM and Col1 fibers by investigating the relationship 
between Col1 fibers and water diffusion and anisotropy in the fourth paper (Chapter 5) in this 
thesis [48].
Imaging modalities and quantification
The work presented here has integrated optical imaging with magnetic resonance imaging 
to take a combined structural, molecular and functional approach in understanding the role of 
Col1 fibers in metastatic dissemination, the relationship between hypoxia and Col1 fibers, and 
the role of Col1 fibers in macromolecular transport and water diffusion.
28
Second harmonic generation microscopy to characterize collagen I fibers. Second harmonic 
generation (SHG) microscopy is a valuable tool for understanding the remodeling of the Col1 
fiber matrix in intact tissue [49].  SHG is a nonlinear optical process that requires a molecule 
without a center of symmetry to produce a signal [50].  These molecules exhibit optical ?2
nonlinearity when the exciting light is polarized non-linearly, and based on the phase matching, 
it gives rise to twice the incident frequency (half the wavelength) referred to as the second 
harmonic [51]. High depth penetration (up to ~ 0.50 mm) with minimum photobleaching and 
phototoxicity is achieved by SHG microscopy [52].  SHG is an intrinsic signal and does not 
require any external labeling.  The SHG excitation wavelength range is 766 nm to 1,064 nm [53].
Col1 fibers have a molecular structure that lacks a center of symmetry and can give rise to a 
second harmonic signal.  Therefore, Col1 fibers can be detected from fresh tissue sections or 
even in vivo via an intra-vital endoscope.  In our studies, to detect Col1 fibers, we have used a
25× lens to acquire z-??????? ??? ?????????????? ???? ??? ?????????? ????? ?? ?-interval of 
approximately ?? ???? ? During this thesis work, we have developed an in-house MATLAB 
(MATLAB 7.4.0, The MathWorks, Natick, MA) code for quantifying the Col1 fiber distribution 
(Chapter 2).  Parameters such as percent fiber volume and inter-fiber distance were calculated to 
quantify Col1 fiber content and distribution [44].  Percent fiber volume was calculated as 
described in equation 1.
??????? ????? ?????? = ????? ?????? ?? ????? ?????? ?? ? ??????? ?? ??? × 100 [Equation 1]
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Inter-fiber distance was calculated by measuring the Euclidean distance from every non-fiber 
voxel to the nearest fiber [44].  The equation for calculating the Euclidean distance in a three-
dimensional matrix between two points p and q is given by equation 2 [54].
?(?, ?) =  ?(?? ? ??)? + (?? ? ??)? + (?? ? ??)? [Equation 2]
The resulting distance matrix maps the distance that represents the space in between Col1 fibers.  
The percent fiber volume and inter-fiber distance parameters of fiber quantification were 
compared in hypoxic versus normoxic tumor regions [44].  We also developed a texture analysis 
technique to understand the fiber patterns seen in these heterogeneous tumor microenvironments 
(see Chapter 5).  We employed statistics based texture analysis to calculate the co-occurrence 
matrix [55].  The co-occurrence matrix calculates the co-occurring gray-level value at a defined 
distance and direction and is given by equation 3 [56].
???,??(?, ?) =  ? ? ?1, ?? ?(?, ?) = ? ??? ?(?+  ??, ? +  ??) = ?0,                                                          ?????????
???????? [Equation 3]
In equation 3, C represents the co-occurrence matrix, I is the image of size (m × n), i and j are 
the gray level image intensities, p and q are the spatial positions, and ?x and ?y are the offsets 
defined by distance and direction at which the gray level is computed [56].  To derive some 
interpretable features from this large co-occurrence matrix, Robert Haralick in 1973 extracted 
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features today known as the Haralick texture features [57] that are calculated from the 2D 
histogram of the image, also referred to as the co-occurrence matrix.  Haralick features include 
energy, entropy, correlation, contrast, variance, sum mean, inertia, cluster shade, cluster 
tendency, homogeneity, max probability, inverse variance and angular second moments [57].
All feature images were displayed and features that did not differentiate between the varying 
fiber patterns were eliminated from further analysis.  The fuzzy c-mean clustering technique [58]
was used to cluster different fiber textures into different categories such as straight fiber texture, 
mixed fiber texture, and wavy fiber texture. 
Optical imaging to detect hypoxia. To detect hypoxia by optical fluorescence imaging, we have 
generated human breast and prostate cancer cells that express enhanced green fluorescent protein 
(EGFP) or red fluorescent protein (RFP) under hypoxic conditions as a hypoxia-inducible factor 
1 (HIF-1)–driven hypoxia sensor.  The cancer cells were stably transfected with a construct that 
contains five copies of the hypoxia response element (HRE) from the promoter of the human 
VEGF-A gene ligated to the complementary DNA of EGFP or RFP, which produced MDA-MB-
231–5HRE-EGFP (Chapter 2) or MDA-MB-231-HRE-RFP (Chapters 4, 5) and PC-3–5HRE-
EGFP (Chapter 2) as previously described [43, 59].  In brief, the HIF-? subunit is unstable in the 
presence of oxygen and eventually proteolysis, but under hypoxic conditions, the HIF-? subunit 
stabilizes and dimerizes with its ? subunit to form stabilized HIF, which then binds HRE sites.  
This binding of HIF to HRE sites acts as a transcriptional activator of all genes in whose 
promoter sequence the HREs can be found.  So when HIF binds to the HRE sites in the above-
mentioned cell lines, the expression of EGFP or RFP is transcriptionally activated and these cells 
start fluorescing in green or red, respectively, under hypoxic conditions [60].  The advantage of 
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using EGFP is that it is a long-lived protein and can be used for high-resolution imaging [61].
EGFP is excited at wavelengths of 450 to 490 nm and emits at 500 nm to 510 nm.  In our first 
paper, we performed our studies using the MDA-MB-231–5HRE-EGFP and PC-3–5HRE-EGFP 
cancer cell lines (Chapter 2, [38]).  
Biological tissues contain melanin, oxyhemoglobin, deoxyhemoglobin, and water, which 
have a high optical absorption for wavelengths below 650 nm, while water also has a high 
optical absorption for wavelengths above 900 nm [62].  Wavelengths between 650 nm and 900 
nm are known to have the least tissue absorption and are best suited for imaging optically labeled 
dyes, called the optical imaging window or the therapeutic window (Figure 2, [63, 64]).  With a 
higher wavelength as compared to EGFP [65], the tdTomato fluorescence signal would give a 
better depth penetration with excitation wavelengths of 543 nm and emission wavelengths of 570 
nm to 620 nm [44, 47, 48], which are closer to the optical imaging window of low tissue 
absorption.  TdTomato has a higher quantum yield of 0.69 as compared to other fluorescent 
proteins in the red wavelength range as well as EGFP (quantum yield = 0.60) [65].  We 
performed our studies in our third and fourth paper using the MDA-MB-231-HRE-RFP breast 
cancer cell line, which expresses the tdTomato RFP (Chapters 4, 5).
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Figure 2: Optical window in tissue. Absorption spectra of important tissue chromophores such as water, 
oxy- and deoxyhemoglobin and melanin are plotted on a logarithmic scale.
From: Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular 
localization. Ana P. Castanoa, b, Tatiana N. Demidovaa, c, Michael R. Hamblin, PhD [64].
Magnetic Resonance imaging. Magnetic resonance imaging (MRI) is a noninvasive imaging 
modality routinely used in the clinical setting for cancer diagnoses and treatment monitoring 
[66].  As a research imaging modality, it non-invasively helps understand tumor architecture and 
phenotype characteristics, which can easily be translated into the clinic [67].  MRI provides 
multiple anatomical parameters such as T1-weighted images, T2-weighted images, and proton 
density (PD) images, as well as functional parameters such as vascular volume, vascular 
permeability surface area product, interstitial fluid transport parameters and water diffusion.  In 
principle, a radiofrequency (RF) pulse is applied to excite nuclear spins in the molecules that 
comprise the tissue to a higher energy level in the presence of a uniform, static magnetic field.  
The nuclear spins undergo relaxation to initial energy levels when the RF pulse is turned off and 
in the process emit RF signal that is detected as an MRI signal [68].  The detected MR signal 
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describes characteristic tissue properties since its signal strength depends on the concentration of 
the nuclear spins and the magneto-chemical environment of the excited nuclei in a given 
magnetic field [68].  MRI has the ability to give 3D high-resolution anatomical images from 
intrinsic contrast mechanisms such as T1 and T2.
Magnetic Resonance imaging to characterize macromolecular transport. To study functional 
effects by MRI, we intravenously injected a macromolecular contrast agent (MMCA) in breast 
cancer bearing mice and acquired MR images over time at regular intervals to study the delivery 
of the MMCA to the tumor and its wash out, which is an imaging technique referred to as 
dynamic contrast enhanced MRI (DCE-MRI).  Different DCE-MRI models have been 
developed, and a model developed by Pathak et al [45] was used in this thesis, which is 
described in detail in Chapter 4.  Briefly, images were acquired in two “phases” corresponding to 
the biphasic kinetics of the macromolecular contrast agent (MMCA) [45], which starts with the 
“early phase” acquisition and ends with the “late phase” acquisition.  The initial 30 minutes of 
“early phase” acquisition included a pre-contrast image and post-contrast images, which were 
repeatedly acquired every 5 minutes [45].  This “early phase” acquisition was processed to 
characterize tumor vascular parameters since the contrast agent was confined within the vascular 
vessels during this time [45].  Tumor vascular parameters such as vascular volume (VV) and 
permeability surface area product (PS) were calculated from the “early phase” acquisition [45].
The drainage of macromolecules in and around tumors either by convection or by the lymphatics 
is a slow event [45].  Hence, the second block of MRI data referred to as the “late phase” was 
acquired for up to 123 minutes post-contrast [45].  The “late phase” acquisition was used to 
characterize the interstitial transport parameters through the ECM [45].  Transport parameters 
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calculated included the number of draining and pooling voxels, draining and pooling rates, and 
exudate volumes (see Chapter 4) [45, 46, 47]. MRI quantification analysis was done using 
software written in house, which was programmed in IDL (ITT Exelis Visual Information 
Solutions, VA USA) and AFNI (NIH software).
Co-registration of optical imaging and MRI data. To combine the DCE-MR images, hypoxia 
images and Col1 fiber distribution, we first co-registered the MR images and 1× optical images 
to calculate transport parameters in hypoxic and normoxic regions of interests (ROIs).  Details of 
this analysis are described in Chapter 4.  Following MRI, the tumor was excised and carefully 
sliced, keeping the orientation as it was in the MRI scanner.  Optical images were co-registered 
to the MR images using affine transformation [69].  The registration error was calculated by 
statistical dice similarity index [70].  The co-registered fluorescence images were masked to 
calculate the DCE-MRI parameters in hypoxic and normoxic regions.  The Col1 fiber 
distribution images were in turn co-registered by affine transformation to the optical images that 
were already co-registered to the MR images.  This co-registration and co-localization analysis 
was performed in MATLAB 7.4.0 (The MathWorks, Natick, MA).  A two tailed t-test was 
performed using Microsoft Office Excel 2010 and p-values of < 0.05 were considered to be 
significant (see Chapter 4).
Magnetic Resonance imaging to characterize water diffusion. Diffusion tensor imaging (DTI) is 
an MRI technique where microscopic tissue structures are revealed by mapping the water 
diffusion  [71].  Water movement is detected using MR, by adding two diffusion sensitizing 
gradients (also called the diffusion gradients) to the classical spin echo MRI sequence.  The first 
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diffusion gradient dephases water molecules and the second diffusion gradient is applied to 
rephase these water molecules.  Ideally, if there is no water movement within the time laps of 
these two gradient pulses, a perfect rephasing of the MR signal would be achieved, but due to 
thermal water motion (or Brownian motion) there is a loss in the rephased MR signal [71].  This 
loss in the MR signal is a measure of water diffusion, and the diffusion coefficient (D) is 
described by Equation 4.
?? =  ??????? [Equation 4]
In Equation 4, S1 represents the acquired MR signal, and S0 is the MR signal with b = 0.  The 
diffusion coefficient D mainly depends on the b-value.  The b-value depends on the strength and 
time duration of the gradient pulse applied  [71].
Water diffusion is measured in the direction of the diffusion gradient.  By applying 
gradients in the X, Y and Z direction, it is possible to measure water movement in any direction  
[71].  Apparent diffusion coefficient (ADC) maps are typically generated by deriving the 
diffusion coefficient with more than one b-value in every pixel as described in Equation 5.
? = ? ln ?????? /(?? ?  ??) [Equation 5]
In Equation 5, D represents the diffusion coefficient, b represents the b-value, and S is the MR 
signal acquired at a given b-value.  Water molecules predominantly diffuse along neuronal fibers 
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as diffusion across fibers is restricted by axonal membrane and, in the case of myelinated axons, 
myelin sheath  [71].  By observing the water’s diffusion direction, it is possible to map 
underlying tissue macrostructures that affect water diffusion  [71].  If water moved freely in all 
directions it would be detected as an isotropic diffusion, but if water had a preferred direction of 
movement, anisotropy would be detected in the water diffusion  [71].  To acquire water diffusion 
in all directions, a model developed by Basser et al has been used, where the measurements from 
all directions are fitted to a 3D ellipsoid [72].  A minimum of six directions are typically required 
to fit the 6 parameters of a 3D ellipsoid, i.e. the three lengths in the longest, middle and shortest 
??????????????????????????????????1???2???3 and their orientations referred to as eigenvectors ?1, ?2,
?3 [71].  We can then calculate the fractional anisotropy (FA) map from the eigenv???????????
described in Equation 6.
?? =  ???
?((?????)?? (?????)?? (?????)?)
????? ???? ???
[Equation 6]
The resulting ADC from different directions is assigned red, green or blue color for the X, Y or Z 
direction, respectively, and each pixel is assigned the color in which direction it has the highest 
ADC value  [71].  Thus, a color-coded map is calculated to display the directionality of the water 
diffusion  [71].
DTI has mainly been used for the investigation and detection of neurological diseases and 
for brain white matter tracking  [71].  Water diffusion in breast tumors is restricted by underlying 
structures such as cells and the components of the ECM  [71].  In this thesis, we have applied 
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DTI to breast cancer xenograft models and clinical breast cancer specimens to correlate water 
diffusion to the corresponding Col1 fiber distribution (Chapter 5, [48]).  The influence of 
hypoxia on water diffusion was also studied, as described in Chapter 5.  In our work here, DTI 
was performed on an 11.7 Tesla spectrometer (Bruker Biospin, Billerica, MA, USA) with six 
diffusion directions (b ~ 1500 s/mm2) and a 11.7 Tesla Bruker system (Bruker Corp., Billerica, 
MA, USA) with up to 30 diffusion direction (b ~ 1500 s/mm2) for our ex vivo and in vivo DTI 
experiments, respectively (Chapter 5, [48]).  The average diffusion-weighted (aDW) images and 
maps of ADC and FA were calculated using DTI Studio image processing software [73].
Thesis outline
The following section features the abstracts of the four papers that comprise this thesis.
Chapter 2 (Paper 1) – Hypoxic Tumor Microenvironments Reduce Collagen I Fiber Density.  
Although the mechanisms through which hypoxia influences several phenotypic characteristics 
such as angiogenesis, selection for resistance to apoptosis, resistance to radiation and 
chemotherapy, and increased invasion and metastasis are well characterized, the relationship 
between tumor hypoxia and components of the extracellular matrix (ECM) is relatively 
unexplored.  The collagen I (Col1) fiber matrix of solid tumors is the major structural part of the 
ECM.  Col1 fiber density can increase tumor initiation, progression, and metastasis, with cancer 
cell invasion occurring along radially aligned Col1 fibers.  Here we have investigated the 
influence of hypoxia on Col1 fiber density in solid breast and prostate tumor models.  Second 
harmonic generation (SHG) microscopy was used to detect differences in Col1 fiber density and 
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volume between hypoxic and normoxic tumor regions.  Hypoxic regions were detected by 
fluorescence microscopy, using tumors derived from human breast and prostate cancer cell lines 
stably expressing enhanced green fluorescent protein (EGFP) under transcriptional control of the 
hypoxia response element.  In-house fiber analysis software was used to quantitatively analyze 
Col1 fiber density and volume from the SHG microscopy images.  Normoxic tumor regions 
exhibited a dense mesh of Col1 fibers.  In contrast, fewer and structurally altered Col1 fibers 
were detected in hypoxic EGFP-expressing tumor regions.  Microarray gene expression analyses 
identified increased expression of lysyl oxidase and reduced expression of some matrix 
metalloproteases in hypoxic compared with normoxic cancer cells.  These results suggest that 
hypoxia mediates Col1 fiber restructuring in tumors, which may impact delivery of 
macromolecular agents as well as dissemination of cells.
Chapter 3 (Paper 2) – Collagen I fiber density increases in lymph node positive breast cancers 
in a pilot study. Collagen I (Col1) fibers are a major structural component in the extracellular 
matrix of human breast cancers.  Second harmonic generation (SHG) microscopic detection of 
Col1 fiber alignment was recently proposed as a novel paradigm for the prediction of human 
breast cancer survival.  In a preliminary pilot study, we have explored the link between Col1 
fiber density in primary human breast cancers and the occurrence of lymph node metastasis.  
Col1 fibers were detected by SHG microscopy in primary human breast cancers from patients 
presenting with lymph node metastasis (LN+) versus without lymph node metastasis (LN-).  
Col1 fiber density, which was quantified using our in-house SHG image analysis software, was
significantly higher in the primary human breast cancers of LN+ versus LN- patients.  Breast 
cancers from LN+ patients had a Col1 fiber volume of 29.22±1.67% and an inter-fiber distance 
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??????????????????????????????????????????????????????????????????-fiber distance of 2.88±0.44 
????????????????????????????- patients.  We also demonstrated that tissue fixation and paraffin-
embedding had no effect on SHG Col1 fiber detection and quantification.  High Col1 fiber 
density in primary breast tumors is associated with breast cancer metastasis and may serve as an 
imaging biomarker of metastasis.
Chapter 4 (Paper 3) – Hypoxic tumor environments exhibit disrupted collagen I fibers and low 
macromolecular transport. Hypoxic tumor microenvironments result in an aggressive 
phenotype and resistance to therapy that leads to tumor progression, recurrence, and metastasis.  
While poor vascularization and the resultant inadequate drug delivery are known to contribute to 
drug resistance, the effect of hypoxia on molecular transport through the interstitium and the role 
of the extracellular matrix (ECM) in mediating this transport are unexplored.  The dense mesh of 
fibers present in the ECM can especially influence the movement of macromolecules.  Collagen 
1 (Col1) fibers form a key component of the ECM in breast cancers.  Here we characterized the 
influence of hypoxia on macromolecular transport in tumors, and the role of Col1 fibers in 
mediating this transport using an MDA-MB-231 breast cancer xenograft model engineered to 
express red fluorescent protein under hypoxia.  Magnetic resonance imaging of macromolecular 
transport was combined with second harmonic generation microscopy of Col1 fibers.  Hypoxic 
tumor regions displayed significantly decreased Col1 fiber density and volume, as well as 
significantly lower macromolecular draining and pooling rates, than normoxic regions.  Regions 
adjacent to severely hypoxic areas revealed higher deposition of Col1 fibers and increased 
macromolecular transport.  These data suggest that Col1 fibers may facilitate macromolecular 
transport in tumors and their reduction in hypoxic regions may reduce this transport.  Decreased 
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macromolecular transport in hypoxic regions may also contribute to poor drug delivery and 
tumor recurrence in hypoxic regions.  High Col1 fiber density observed around hypoxic regions 
may facilitate the escape of aggressive cancer cells from hypoxic regions.    
Chapter 5 (Paper 4) – Manuscript (DTI-SHG) Collagen 1 (Col1) fibers play an important role 
in macromolecular transport and cancer cell dissemination.  Our goal in this study was to 
understand the influence of Col1 fibers on water diffusion, and to examine the potential of using 
noninvasive diffusion tensor imaging (DTI) to detect Col1 fibers in breast lesions.  We have 
previously observed in genetically engineered human MDA-MB-231 breast cancer xenograft 
tumors that fluoresce under hypoxia, relatively low amounts of collagen 1 fibers in fluorescent 
hypoxic regions.  The same tumor model was used to further investigate the relationship between 
Col1 fibers, water diffusion and anisotropy, and hypoxia.  We observed for the first time that 
water diffusion and anisotropy followed Col1 fiber distribution in human breast cancer 
specimens.  In regions with low Col1 fiber content, apparent diffusion coefficient (ADC) and 
fractional anisotropy (FA) values decreased significantly as compared to regions containing 
dense Col1 fibers (p-value < 0.05).  In the breast cancer xenograft model, we observed that 
hypoxic regions with significantly lower Col1 fiber volume had significantly lower ADC and FA 
values as compared to normoxic tumor regions with higher Col1 fiber volume.  Lastly, we 
performed in vivo DTI measurements to confirm that DTI patterns in tumors observed in vivo
spatially co-localized with DTI patterns observed ex vivo in the same tumors.  These studies have 
identified the potential use of noninvasive DTI as a biomarker to detect Col1 fiber density and 
further confirm the importance of Col1 fibers in molecular transport through the ECM.
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Abbreviations footnote
Col1, Collagen 1
ECM, extracellular matrix
EGFP, enhanced green fluorescent protein
FOV, field of view
HIF, hypoxia inducible factor
HRE, hypoxia response element
K-S, Kolmogorov-Smirnov
LOX, lysyl oxidase
MMP, matrix metalloproteinase
P3H, prolyl-3-hydroxylases
P4H, prolyl-4-hydroxylases
PIN, prostatic intraepithelial neoplasia
PLOD, procollagen lysyl-hydroxylases
Pro-Col1, procollagen type I
ROI, region of interest
SCID, severe combined immunodeficient
SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis
SHG, second harmonic generation
TGF, transforming growth factor
uPA, urokinase plasminogen activator
uPAR, urokinase plasminogen activator receptor
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Abstract
Although the mechanisms through which hypoxia influences several phenotypic 
characteristics such as angiogenesis, selection for resistance to apoptosis, resistance to radiation 
and chemotherapy, and increased invasion and metastasis are well characterized, the relationship 
between tumor hypoxia and components of the extracellular matrix (ECM) is relatively
unexplored. The collagen I (Col1) fiber matrix of solid tumors is the major structural part of the 
ECM. Col1 fiber density can increase tumor initiation, progression, and metastasis, with cancer 
cell invasion occurring along radially aligned Col1 fibers. Here we have investigated the 
influence of hypoxia on Col1 fiber density in solid breast and prostate tumor models. Second 
harmonic generation (SHG) microscopy was used to detect differences in Col1 fiber density and 
volume between hypoxic and normoxic tumor regions. Hypoxic regions were detected by 
fluorescence microscopy, using tumors derived from human breast and prostate cancer cell lines 
stably expressing enhanced green fluorescent protein (EGFP) under transcriptional control of the 
hypoxia response element. In-house fiber analysis software was used to quantitatively analyze 
Col1 fiber density and volume from the SHG microscopy images. Normoxic tumor regions 
exhibited a dense mesh of Col1 fibers. In contrast, fewer and structurally altered Col1 fibers 
were detected in hypoxic EGFP-expressing tumor regions. Microarray gene expression analyses 
identified increased expression of lysyl oxidase and reduced expression of some matrix 
metalloproteases in hypoxic compared with normoxic cancer cells. These results suggest that 
hypoxia mediates Col1 fiber restructuring in tumors, which may impact delivery of 
macromolecular agents as well as dissemination of cells. 
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Introduction
Tumors display hypoxic environments that primarily arise from their abnormal and 
chaotic vasculature [1]. Hypoxia triggers multiple signaling cascades that significantly affect 
biologic outcomes including angiogenesis, selection for resistance to apoptosis, resistance to 
radiation and chemotherapy, and increased invasion and metastasis [2, 3]. The extracellular 
matrix (ECM) plays an important role in drug delivery as well as invasion and metastasis, but the 
relationship between tumor hypoxia and ECM components is relatively unexplored. 
The ECM in breast and prostate tumors is composed of a complex meshwork of fibrillar 
collagens, glycoproteins, and proteoglycans [4, 5], which profoundly affect metastasis, as well as 
proliferation, angiogenesis, adhesion, migration, invasion, and drug delivery [4–9]. Collagen I 
(Col1) fibers are the major structural ECM component in breast [4, 10–12] and prostate tumors 
[8, 13, 14]. A recent study demonstrated a causal relationship between Col1 fibers and metastasis 
in a bitransgenic mouse model with increased stromal Col1, in which high Col1 fiber density was 
able to significantly increase mammary tumor initiation, progression, and lung metastasis [11]. 
Cancer cell invasion in this mouse model started at the tumor-stromal interface in the primary 
tumor along radially aligned Col1 fibers [10]. The presence of a fibrotic focus in central tumor 
regions of breast cancer patients has been suggested as a prognostic factor and surrogate marker 
for hypoxia in breast tumors [15, 16]. A recent study in a carcinogen-induced rat mammary 
carcinoma model indicated that, overall, more fibrotic tumors were also more hypoxic [17]. Cells 
of myofibroblast phenotype in the reactive stroma of Gleason 3–scored prostate cancers 
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exhibited an elevated Col1 synthesis, which was first observed in activated peri-acinar 
fibroblasts adjacent to prostatic intraepithelial neoplasia [8]. 
Col1 fiber biosynthesis, maturation, and deposition is a multistep process, initiated by the 
Col1A1 and Col1A2 genes that produce the pro-?????? ???? ???-?????? ???????? ?????????????? ???
procollagen type I (pro-Col1). Intracellular prolyl-3/4-hydroxylases, lysyl hydroxylases, and 
protein disulfide isomerases further modify these pro-?????? ???? ???-?????? ??????? ??? ????? ???-
Col1 triple helices [18, 19]. Fibroblasts are primarily responsible for synthesizing and secreting 
pro-Col1, whereas hepatic stellate cells [20], osteoblasts [21], odontoblasts [21], and hypoxic 
smooth muscle cells [22] also have the ability to produce pro-Col1. Extracellular procollagen N-
and C-proteinases cleave the pro-Col1 propeptide ends of secreted pro-Col1, thereby initiating 
the self-assembly of collagen microfibrils [19]. Extracellular lysyl oxidase (LOX) covalently 
cross-links Col1 microfibrils with each other to form strong and stable mature Col1 fibers that 
surround cells within the ECM [19]. Fibrillar Col1 profoundly affects the mechanical properties 
of tissues, with high Col1 fiber content corresponding to more rigid and less compressible tissue 
properties [19]. Breast [23, 24] and prostate cancer cells [8] can stimulate Col1 synthesis in 
tumor-associated fibroblasts and reorganize a previously random Col1 fiber matrix [10]. In 
addition, Col1 fibers in breast and prostate tumors can be degraded and remodeled by matrix 
metalloproteinase (MMP)-1 and MMP-14 (also referred to as MT1-MMP), which are secreted by 
or located on the cancer cells [25]. Whereas MMP-1 and MMP-14 initiate Col1 fiber degradation 
in the tumor microenvironment, further breakdown is mediated by MMP-2, MMP-9, MMP-12, 
and MMP-13 [26, 27], as well as cathepsins and the urokinase plasminogen activator (uPA) and 
uPA receptor (uPAR) system [28]. 
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In normal tissues, hypoxic environments promote the formation of collagen deposits [18,
29, 30]. The influence of hypoxia on Col1 remodeling in solid tumors in vivo is relatively 
unexplored. The purpose of our study was to determine the effect of hypoxia on Col1 fibers in 
solid breast and prostate tumor models. 
We used second harmonic generation (SHG) microscopy to detect Col1 fibers in these 
tumor models. SHG microscopy detects the intrinsic signal of the noncentrosymmetric physical 
properties of Col1 fibers without an exogenous optical imaging agent [31, 32]. SHG microscopy 
has been previously used in tumor xenografts to assess ECM integrity [31]. With SHG 
microscopy of human specimens, Col1 fibers in breast tumors were found to be straighter and 
denser than the fibers in benign lesions or normal breast tissue [32]. Here, for the first time, we 
have applied SHG microscopy to detect differences in Col1 fibers between hypoxic and 
normoxic tumor regions. The studies were performed using tumors derived from human breast 
and prostate cancer cell lines stably expressing enhanced green fluorescent protein (EGFP) under 
transcriptional control of five copies of a hypoxia response element (HRE), which have already 
been used in several studies in our laboratory [33, 34]. To analyze Col1 fiber density and volume 
from the SHG microscopy images, we developed an in-house fiber analysis software. Normoxic 
tumor regions without fluorescence exhibited a dense mesh of Col1 fibers, whereas fewer and 
structurally altered Col1 fibers were detected in hypoxic EGFP-expressing tumor regions. 
Microarray gene expression analyses indicated increased LOX expression and reduced 
expression of MMPs in hypoxic cancer cells. These results suggest that tumor hypoxia can result 
in Col1 fiber restructuring, which may influence several ECM-related characteristics such as 
macromolecular transport and cancer cell dissemination.
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Materials and Methods
Cell Lines and Tumor Models
The triple-negative metastatic human breast cancer cell line MDAMB-231 [35] and the 
androgen-independent human prostate cancer cell line PC-3 [36] were obtained from the 
American Type Culture Collection (ATCC, Rockville, MD). Wild-type MDA-MB-231 [37] and 
PC-3 [38] cells were maintained as previously described. To generate MDA-MB-231 and PC-3
cells that express EGFP under hypoxic conditions as a hypoxia-inducible factor 1 (HIF-1)–driven 
hypoxia sensor, MDA-MB-231 and PC-3 cells were stably transfected with a construct 
containing five copies of the HRE of the human VEGF-A gene ligated to the complementary 
DNA of EGFP, which produced MDA-MB-231–5HRE-EGFP and PC-3–5HRE-EGFP as 
previously described [33, 34]. EGFP expression was verified in hypoxic cell cultures by 
fluorescence microscopy and in corresponding protein lysates by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis and immunoblot analysis with anti-EGFP antibody (BD 
Biosciences, San Jose, CA) as previously described [33, 34]. In our previous studies, we 
observed detectable EGFP expression within 6 hours of exposure to less than 1% O2 and robust 
EGFP expression by 20 hours in HREEGFP–expressing cells in culture [33]. Cells were 
routinely characterized for hypoxia–driven EGFP expression before inoculation in mice. 
Two million MDA-MB-231–5HRE-EGFP cells were orthotopically inoculated in the 
mammary fat pad of anesthetized female severe combined immunodeficient mice as previously 
described [39] to grow solid MDA-MB-231–5HRE-EGFP xenografts. Solid PC-3–5HREEGFP 
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prostate tumor xenografts were obtained by inoculating 2 × 106 PC-3–5HRE-EGFP cells in 0.1 
ml of Hank’s balanced salt solution (Sigma-Aldrich, St Louis, MO) subcutaneously in the right 
flank of male severe combined immunodeficient mice [33, 34]. Tumor xenografts reached their 
final experimental size within 8 weeks. In our previous studies, low oxygen tension was detected 
in several EGFP fluorescing regions (pO2 < 0.6 mm Hg), and higher oxygen tensions (5.0 mm 
Hg < PO2 < 40.0 mm Hg) comparable to normal muscle tissue (23.0 mm Hg < pO2 < 50.0 mm 
Hg) were detected in several non-fluorescing peripheral tumor regions measured with a fiber-
optic oxygen probe inserted in vivo [33]. 
SHG and Confocal Microscopy 
Animals were sacrificed, tumor xenografts were excised for ex vivo fluorescence 
microscopy, and three to five serial 2-mm-thick fresh tissue slices were cut using an acrylic 
adjustable tissue slicer (12 mm depth up to 25mmwidth; Braintree Scientific, Inc., Braintree, 
MA) and tissue slicer blades (Braintree Scientific, Inc.). These serial fresh xenograft tissue slices 
were each placed on individual microscope slides (Fisher brand catalog number 12-550-34; 
Fisher Scientific, Pittsburgh, PA), which were stored in a box containing ice on the bottom, in 
which the slides were located on a perforated plate at approximately 1 cm above the ice to ensure 
a tissue temperature of approximately 4°C to avoid tissue degradation. For microscopic 
measurements, a given slide holding a tumor slice was taken out of the icebox and placed under 
the microscope for the time of microscopic imaging. In between microscopic measurements, the 
fresh tumor slices were returned to the icebox to keep the tissue at 4°C, and they were 
periodically moistened with saline to avoid dehydration of the tissue. EGFP expression in these 
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tumor slices was detected by fluorescence microscopy using a 1× objective attached to a Nikon 
inverted microscope, equipped with a filter set for 450 to 490 nm excitation and 500 to 550 nm 
emission, and a Nikon Coolpix digital camera (Nikon Instruments, Inc., Melville, NY). These 1× 
images were used to coarsely locate hypoxic and normoxic tumor regions in subsequent SHG 
microscopic acquisitions. 
For SHG microscopy, a microscope slide holding a fresh 2-mm-thick tissue slice was 
removed from the icebox and placed under the objective of a multiphoton system. After SHG 
microscopy, the slide was moistened and returned to the icebox. The SHG microscopy of tumor
slices was performed on a Nikon/Bio-Rad or a Zeiss LSM 710 NLO Meta multiphoton 
microscopy system (Carl Zeiss Micro Imaging, Inc., Thornwood, NY). The Nikon E600FN 
upright research fluorescence microscope was equipped with a Bio-RadMRC-1024/2-P
multiphoton attachment (Bio-Rad, Hercules, CA) and a Tsunami 3941 M1S femtosecond mode-
locked Ti:Sa pulsed laser (Spectra Physics, Mountain View, CA) pumped by a 10-W Millennia
X solid-state laser (Spectra Physics). Laser light of 880 nm was used as an incident light for 
generation of the SHG Col1 signal and for two-photon excitation of EGFP fluorescence. The 
SHG signal from Col1 fibers was detected at 410 to 470 nm, and the EGFP fluorescence was 
detected at 500 to 560 nm. The Zeiss 710 NLO Meta confocal microscope (Carl Zeiss Micro-
Imaging, Inc.) was equipped with a 680- to 1080-nm tunable Coherent Chameleon Vision II laser 
(Coherent, Inc., Santa Clara, CA). For SHG Col1 microscopy, incident laser light at 880 nm was 
used, and the SHG signal was detected at 410 to 470 nm. Simultaneously, EGFP was excited
with the 488-nm laser line and detected at 500 to 560 nm. On both microscope systems, a 25× 
lens was used to acquire confocal z-stacks of ???????????????????? thickness with a z-interval 
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?????????????????????? Neither the SHG nor the EGFP signal of a given field of view (FOV) on
a given tumor tissue slice changed over time when imaging the same FOV multiple times within 
one imaging session, for example, once in the beginning and once at the end of an imaging 
session.
After microscopy, fresh tumor slices were frozen in Tissue Tek OCT freezing compound 
(Sakura Finetek USA, Inc., Torrance, CA). Frozen slices were cryo-sectioned with a 
microcryotome (Microm International, ??????????????????????????????????????????????????????
paraformaldehyde (Sigma-Aldrich) solution, stained for nuclei with Hoechst 33342 (Invitrogen 
Corp, Carlsbad, CA), and mounted with Faramount aqueous mounting medium 
(DakoCytomation, Carpinteria, CA). Two-photon excitation of Hoechst 33342 at 880 nm 
together with excitation of the SHG signal was performed on these whole-mount sections.
Hoechst was detected at 450 to 500 nm, and the SHG Col1 signal was detected at 400 to 450 nm. 
EGFP was single-photon excited at 488 nm and detected at 500 to 560 nm.
Image and Statistical Analysis
Image analysis to quantify (1) the Col1 fiber distance distribution and (2) the Col1 fiber 
volume was performed using in-house software. This software was written in Matlab using 
MATLAB 7.4.0 (The MathWorks, Natick, MA) and described in detail in the Results section. 
Regions of interest (ROIs) containing defined percentages of hypoxic EGFP fluorescing cells 
were drawn and analyzed with this software. A one-sided ?? ????? ???????????????????? ??????????
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significant differences between hypoxic and normoxic ROIs using Microsoft Office Excel 2007 
(Microsoft, Redmond, WA). P values < .05 were considered to be significant.
Gene Expression Analysis with Affymetrix Microarrays of Hypoxic versus Normoxic Cells
Wild-type MDA-MB-231 and PC-3 cells were exposed to hypoxic conditions in a 
commercially available culture chamber (BioSpherix Ltd, Redfield, NY) for 24 and 48 hours. 
This humidified culture chamber was maintained at 37°C and equilibrated with a mixture of
0.3% to 0.7% O2 and 5% CO2 for the required time intervals, using controlled N2 and CO2 gas 
infusions (BioSpherix). Controls were placed in a standard cell culture incubator at 37°C in a 
humidified atmosphere containing 21% O2 and 5% CO2. Total cellular RNA was isolated from 
approximately 107 cells, using the RNeasy Mini Kit (Qiagen, Inc., Valencia, CA) and 
QIAshredder homogenizer spin columns (Qiagen) as previously described [37]. The microarray 
hybridization was performed at the Johns Hopkins Medical Institution’s Microarray Core 
Facility using the Human Genome U133 Plus 2.0 GeneChip array (Affymetrix, Inc, Santa Clara, 
CA) and the Affymetrix GeneChip platform, Agilent GeneArray Scanner, and Micro Array Suite 
5.0 software by Affymetrix as previously described [37]. To estimate the gene expression 
signals, data analysis was conducted on the chips’ cell intensity file probe signal values at the 
Affymetrix probe pair (perfect match probe and mismatch probe) level, using statistical
techniques and the robust multiarray analysis package as previously described [37, 40, 41]. The 
posterior probabilities of the differential expression of genes were estimated for hypoxic versus 
normoxic MDAMB-231 cells and hypoxic versus normoxic PC-3 cells. The criterion of the 
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posterior probability > 0.5, which means the posterior probability is larger than by chance, was 
used to produce the differentially expressed gene lists. All computations were performed under 
the R environment as previously described [37].
Results
To achieve quantitative analysis of Col1 fibers from SHG images, we developed in-house 
image analysis software. A major challenge in the quantitative analysis of Col1 fiber distribution 
and volume occurs because of the complex intersecting patterns of the fibers in three spatial 
dimensions, which is apparent in the raw data set of z-sections in Figure 1. We therefore 
developed a practical and intuitive approach to characterize these distribution patterns by 
analyzing the interstices in the fibrillar mesh outlined in Figure 2.
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Figure 1: Complete representative raw data set showing the z-series of EGFP images (top panel) and 
SHG images (middle panel) in gray scale, as well as the merged images displaying the EGFP channel in 
green and the SHG channel in red. ???????????????????
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Figure 2: Quantification of fiber distance distribution with in-house software: (A) representative raw 
image data shown as z-projection of the Col1 fibers (red) in a hypoxic (green) region; (B) representative 
example of software detection of hypoxic cells (green in raw image (A)) independent of fluorescence 
intensity and threshold of raw images; preprocessing using the filter (C) to identify fiber-like objects (red) 
among various non–fiber-like objects in the image to produce (D) the corresponding Col1 fiber image; 
(E) computing the distances three-dimensionally to the surrounding fibers from each voxel to determine 
the nearest distance to a fiber. The fiber volume is computed as an additional parameter.
The analytical approach presented in Figure 2 was applied to quantify the Col1 fiber 
distances and volumes from tumor xenograft models. Figure 2A shows the representative raw 
image displayed as a z-projection of the three-dimensional data set, which was generated from 
the z-sections in Figure 1. Figure 2B shows that the software was able to detect hypoxic cells 
independent of variability in the dynamic range of the green fluorescence signal in the images. 
The hypoxic ROIs in our analysis were defined as containing more than 80% green fluorescing 
hypoxic cells; normoxic regions contained less than 1% of green fluorescing hypoxic cells in the 
ROI. Images were preprocessed to exclude noise and non fibrillar shapes as shown in Figure 2C. 
Figure 2D shows that the software detected Col1 fiber structures from the raw image. A three-
dimensional volume of the Col1 fiber mesh within a given ROI was selected, and Euclidean 
distances from each empty voxel to the nearest Col1 fiber voxel were computed to quantify the 
fiber distances within the mesh (Figure 2E). This provided a cumulative histogram of the 
distance distribution as a measure of porosity of the mesh as shown in the subsequent figures. In 
addition, a second parameter, the Col1 fiber volume, was quantified using our in-house three-
dimensional image quantification software. Figure 3 shows the performance of this software on 
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an artificial training data set. We manually generated a sparser fiber image A as shown in Figure 
3A, which was modified in Figure 3B with a few additional lines representing fibers to give 
image B. Our software was able to correctly detect a shift toward a denser fiber distribution 
(Figure 3C) and an increased fiber volume (Figure 3D) for image B compared with image A. 
Compared with analysis methods based on Fourier analysis [32], our method derived parameters 
that are visually evident in the images. Because of its robustness, the method requires minimal 
preprocessing steps that can be adopted to varying image quality. 
Figure 3: Performance of our software on a training data set of two artificial manually drawn fiber 
images of (A) sparser fibers and (B) denser fibers, in which just a few more lines representing fibers were 
added to image A. The software correctly detected (C) the shift toward a denser fiber distribution as well 
as (D) the increase in fiber volume in image B compared with that in image A.
A representative example from an MDA-MB-231 breast tumor is shown in Figure 4 and 
that from a PC-3 prostate tumor is shown in Figure 5. Low-power microscopic images covering 
2-mm-thick tumor slices from representative MDA-MB-231–5HRE-EGFP (Figure 4A) and PC-
3–5HRE-EGFP (Figure 5A) tumors demonstrated that the hypoxic green fluorescing regions 
were heterogeneously distributed throughout the tumors.
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Figure 4: Hypoxic regions are heterogeneously distributed throughout MDA-MB-231 tumors as evident 
in a representative set of (A) bright-field, green fluorescence, and overlay microscopic images (left to 
right) of a fresh 2-mm-thick section from a solid MDA-MB-231–5HRE-EGFP breast tumor. 
Representative SHG Col1 fiber (red) and hypoxia (green) images are from (B) a normoxic and (C) a 
hypoxic FOV, displayed as z-projection (left) and as three-dimensionally reconstructed image (right). We 
computed (D) the mean distance distribution to the nearest fiber voxel as a measure of fiber density and 
(E) the percentage of fiber voxels within the ROI (mean±SD). Data are from three tumors. Hypoxic 
regions had more than 80%, and normoxic regions had less than 1% of hypoxic EGFP-expressing cells in 
the ROI. Hypoxic tumor regions contained less dense and fewer Col1 fibers than normoxic regions in 
MDA-MB-231 breast tumor xenografts stably expressing HRE-EGFP.
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Hypoxic regions of MDA-MB-231 breast as well as PC-3 prostate tumor xenografts 
displayed significantly sparser, more porous Col1 fibers than normoxic regions as evident from 
representative microscopic images of normoxic (Figures 4B and 5B) and hypoxic regions 
(Figures 4C and 5C). Figures 4, B and C, and 5, B and C, show z-projections of the z-stack on 
the left and the corresponding three-dimensional display of the image on the right. The median 
hypoxic Col1 inter fiber distances were significantly (P = 0.050 for MDA-MB-231, n = 3-5; P = 
0.002 for PC-3, n = 9) higher compared with the median normoxic Col1 inter fiber distances for
both breast (Figure 4D, n = 3-5 ROIs) and prostate tumor xenografts (Figure 5D, n = 9 ROIs). 
Cumulative histograms of the Col1 fiber distance distributions of breast (Figure 4D) and prostate 
(Figure 5D) tumor xenografts demonstrated that the mean Col1 fiber distance distribution shifted 
toward longer inter fiber distances in hypoxic compared with normoxic regions. This increased 
Col1 fiber distance in hypoxic tumor areas implied a more porous distribution of Col1 fibers in 
hypoxic versus normoxic tumor regions. The Col1 fiber volume was significantly lower (breast 
tumor model: P = 0.0428, n = 3-5 ROIs in Figure 4E; prostate tumor model: P = 0.0004, n = 9 
ROIs in Figure 5E) in hypoxic than in normoxic regions in both tumor models, consistent with 
the fewer, more porous distribution of Col1 fibers in hypoxic tumor regions. Using Hoechst 
33342 staining and fluorescence microscopic detection of cell nuclei, we confirmed that an equal 
number of cells and comparable cell density were present in hypoxic and normoxic regions 
ofMDA-MB-231 and PC-3 tumor xenografts, as shown in representative images from MDA-
MB-231 tumors in Figure 6.
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Figure 5: Consistent with Figure 2, hypoxic regions are heterogeneously distributed throughout solid PC-
3 tumors as evident in a representative set of (A) bright-field, green fluorescence, and overlay 
microscopic images (left to right) of a fresh 2-mm-thick section from a solid PC-3–5HRE-EGFP prostate 
tumor. Representative SHG Col1 fiber (red) and hypoxia (green) images are from (B) a normoxic and (C) 
a hypoxic FOV, displayed as z-projection (left) and as three-dimensionally reconstructed image (right). 
We computed (D) the mean distance distribution to the nearest fiber voxel as a measure of fiber density 
and (E) the percentage of fiber voxels within the ROI (mean ± SD). Data are from three tumors. Hypoxic 
regions had more than 80%, and normoxic regions had less than 1% of hypoxic EGFP-expressing cells in 
the ROI. Hypoxic tumor regions contained less dense and fewer Col1 fibers than normoxic regions in PC-
3 prostate tumor xenografts stably expressing HRE-EGFP.
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Figure 6: Representative z-sections of Hoechst 33342–stained whole-mount sections demonstrate that 
cells are evenly distributed throughout the tumors, independent of local fiber density. Col1 fibers are 
???????????????????????????????????????????????????????????????????????
We investigated differences in gene expression of factors secreted by hypoxic versus 
normoxic cancer cells that can influence Col1 synthesis, cross-linking, and degradation. A 
comparison of gene expression analyzed using Affymetrix Human Genome U133 Plus 2.0 
GeneChip arrays of hypoxic versus normoxic cells for MDA-MB-231 breast cancer cells is 
shown in Table 1 and that for PC-3 prostate cancer cells is shown in Table 2. Both cancer cell 
types showed increased expression of LOX under hypoxic conditions in cell culture. In addition, 
some MMPs were under expressed under hypoxic conditions, such as MMP-3 in MDA-MB-231
breast cancer cells and MMP-1 and MMP-16 in prostate cancer cells. The uPAR was 
overexpressed in hypoxic PC-3 cells compared with normoxic controls. Other than the reported 
genes, no differences were detected in any other MMPs, cathepsins, tissue inhibitors of 
metalloproteases, or genes involved in Col1 synthesis and degradation. Additional studies are 
currently underway to elucidate the molecular differences leading to the changes on Col1 fiber 
patters in hypoxic compared with normoxic tumor regions.
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Table 1: Genes of secreted factors that are involved in Col1 synthesis and breakdown and contained on 
the affymetrix human genome U133 Plus 2.0 Array, which are differentially expressed in hypoxic versus 
normoxic human MDA-MB-231 breast cancer cells.
Gene Group Gene Title Gene Symbol
Representative 
Public ID
Fold 
Change Probability
Col1 synthesis/ 
crosslinking Lysyl oxidase LOX NM_002317 5.2446 0.9435
Matrix metallo-
proteases
matrix metallopeptidase 
3 (stromelysin 1, 
progelatinase)
MMP3 NM_002422 -3.9105 0.7526
Table 2: Genes of secreted factors that are involved in Col1 synthesis and breakdown and contained on 
the affymetrix human genome U133 Plus 2.0 Array, which are differentially expressed in hypoxic versus 
normoxic human PC-3 prostate cancer cells.
Gene Group Gene Title Gene Symbol
Representative 
Public ID
Fold 
Change Probability
Col1 synthesis/ 
crosslinking Lysyl oxidase LOX NM_002317 3.2023 1.000
Matrix metallo-
proteases
matrix metalloproteinase 
1 (interstitial collagenase) MMP1 NM_002421 -1.9742 0.9966
matrix metalloproteinase 
16 (membrane-inserted) MMP16 U79292 -2.1110 0.9995
uPA System 
Proteases
plasminogen activator, 
urokinase receptor PLAUR U08839 2.1025 0.9974
Discussion
Since the discovery of HIF-1 and HREs as transcriptional controls in multiple genes [42], 
it has become evident that tumor hypoxia is associated with a more aggressive cancer phenotype 
[43]. In this study, we demonstrated for the first time that hypoxic regions in solid tumors 
contain significantly fewer and less dense Col1 fibers. We also developed a practical, intuitive, 
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and robust image analysis approach to quantitatively characterize differences in Col1 fiber 
matrices and provide parameters that are visually evident, such as the Col1 fiber distance 
distribution and the Col1 fiber volume. Col1 fibers are the major structural ECM component in 
breast [4, 10–12] and prostate tumors [8, 13, 14], and high Col1 fiber density and elevated Col1 
synthesis have been associated with mammary tumor initiation, progression, and metastasis [10,
11] and prostate carcinogenesis [8].Our data show that hypoxia significantly reduced the Col1 
fiber matrix density in invasive, metastatic solid breast and prostate tumor models, whereas 
normoxic tumor regions contained a dense meshwork of Col1 fibers. Patient and animal model 
data associating increased fibrosis with elevated hypoxia do not contradict our current study 
because these studies did not compare hypoxic and normoxic regions within a given tumor but 
rather evaluated overall tumor hypoxia within a given tumor, based on staining Figure 5. 
Consistent with Figure 2, hypoxic regions are heterogeneously distributed throughout solid PC-3
tumors as evident in a representative set of (A) bright-field, green fluorescence, and overlay 
microscopic images (left to right) of a fresh 2-mm-thick section from a solid PC- hypoxia 
markers, with respect to overall fibrosis staining in the same tumor [15–17]. Taken together, 
these findings indicate that although a dense Col1 matrix may be required for tumor initiation, its 
presence may not be necessary at later stages of tumor growth when hypoxia occurs. Our data 
suggest that once solid tumors are large enough for hypoxia to occur because of insufficient and 
chaotic vascularization, these hypoxic regions can acquire a loose and porous Col1 fiber matrix. 
Our previous validation of HRE-controlled expression of EGFP in cells in culture as well as in 
hypoxic tumor regions in vivo suggests that EGFP expression detected hypoxia of 1% or less that 
had existed for at least 6 hours and was within an oxygen tension of pO2 less than 0.6 mmHg 
[33]. Changes in the Col1 fiber matrix were therefore characterized in these chronically hypoxic 
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regions. Future studies of the effects of acute hypoxia, reoxygenation, and transient hypoxia on 
the Col1 fiber matrix as well as the causative changes in gene expression will provide further 
insight into the regulation of Col1 fibers in tumors. 
Col1 fiber degradation through proteolytic enzymes and reduced Col1 fiber synthesis are 
possible explanations for the less dense Col1 fiber matrix in hypoxic tumor regions. In terms of 
degradative processes, hypoxic conditions can increase the expression and activity of MMP-1
[44–46] and MMP-14 [47, 48], especially in cancer cells. However, our microarray-based gene 
expression analysis in cell cultures revealed a reduction in MMP-3 or MMP-1 and MMP-16 
expression on exposure to hypoxia in MDA-MB-231 breast or PC-3 prostate cancer cells, 
respectively. These cancer cell lines may behave differently under cell culture conditions 
compared with the in vivo situation in solid tumors. Further studies are necessary to compare the 
expression and activity levels of MMPs from cells within the tumor microenvironment, such as 
stromal fibroblasts, endothelial cells, and macrophages, among others. Other degradative 
pathways, such as the uPA-initiated cascade, may be involved in degrading Col1 fibers in 
hypoxic tumor regions. In this cascade, secreted uPA binds to cellular uPARs to catalyze the 
conversion of plasminogen to plasmin, which is a broad-spectrum enzyme that results in 
immediate ECM degradation or activation of multiple MMPs [28].Hypoxic PC-3 cells in tissue 
culture showed higher uPA activity levels than oxygenated PC-3 cells [38]. Exposure of MDA-
MB-231 cells to hypoxia was shown to increase uPAR expression along with increasing the 
invasiveness of these cells [49, 50], which would support the possibility of uPAR-mediated Col1 
degradation in hypoxic tumor regions. 
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In terms of Col1 synthesis, hypoxia has been found to stimulate Col1 fiber synthesis and 
cross-linking as outlined here. Hypoxia has been observed to activate the Col1A1 promoter 
through transforming growth factor ??????????????????????????-1 [21, 22] or by posttranscriptional 
processes [30]. Hypoxia was also shown to stimulate the expression of a cluster of hydroxylases 
required in the posttranslational processing of Col1 fibers [18]. Expression of these 
hydroxylases, such as prolyl-4-hydroxylases and procollagen lysyl-hydroxylase, may be 
coordinated by HIF-1 [18]. LOX, which cross-links Col1 microfibrils, has recently been 
implicated in hypoxia-induced metastasis [51, 52]. LOX is regulated by HIF-1, and secreted 
LOX is responsible for the invasive/metastatic properties of hypoxic human cancer cells through 
focal adhesion kinase activity and cell-matrix adhesion [51, 52]. The gene expression analysis in 
our study revealed a significant increase in LOX expression under hypoxia in invasive/metastatic 
breast and prostate cancer cells alike, which is in good agreement with these studies [51, 52]. 
Co11 fiber density and volume will ultimately depend on the net balance between synthesis and 
degradation. The less dense, porous Col1 fiber matrix observed in hypoxic tumor regions 
suggests that degradation may have dominated over synthesis in chronically hypoxic tumor 
regions. 
In summary, using combined SHG and fluorescence microscopy and a newly developed 
image analysis approach to quantify fiber structures, we have demonstrated that hypoxia resulted 
in a more porous and reduced Col1 fiber matrix in hypoxic regions of solid tumors in vivo. The 
use of SHG microscopic detection of Col1 fibers to assess ECM integrity, which is an intrinsic 
contrast mechanism, may prove clinically useful in the future in minimally invasive procedures, 
such as biopsies or ablations, in which a fiber-optic micro-endoscope can be implemented as part
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of the biopsy or ablation needle. In normal tissue, Col1 fibers and the ECM, in general, are 
structured to guide interstitial fluid to the lymphatics [53]. Whereas hypoxia undoubtedly alters 
Col1 fibers in these human tumor xenograft models, the role of this Col1 restructuring in 
macromolecular transport and mediating cancer cell dissemination requires further investigation.
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Abstract
Collagen I (Col1) fibers are a major structural component in the extracellular matrix of 
human breast cancers.  In a preliminary pilot study, we have explored the link between Col1 
fiber density in primary human breast cancers and the occurrence of lymph node metastasis.  
Col1 fibers were detected by second harmonic generation (SHG) microscopy in primary human 
breast cancers from patients presenting with lymph node metastasis (LN+) versus without lymph 
node metastasis (LN-).  Col1 fiber density, which was quantified using our in-house SHG image
analysis software, was significantly higher in the primary human breast cancers of LN+ (fiber 
volume = 29.22+1.67%, inter-fiber distance = 2.25+0.17 μm) versus LN- (fiber volume = 
20.33+2.27%, inter-fiber distance = 2.88+0.44 μm) patients.  Texture analysis by evaluating the 
co-occurrence matrix and the Fourier transform of the Col1 fibers proved to be significantly 
different for the parameters of co-relation and energy, as well as aspect ratio and eccentricity for 
LN+ versus LN- cases.  We also demonstrated that tissue fixation and paraffin-embedding had 
negligible effect on SHG Col1 fiber detection and quantification.  High Col1 fiber density in 
primary breast tumors is associated with breast cancer metastasis and may serve as an imaging 
biomarker of metastasis.
Introduction
The extracellular matrix (ECM) in primary breast cancers is significantly altered 
compared to normal breast tissue and may provide new biomarkers for cancer diagnosis [1-4], 
metastasis prediction [5, 6], and prognosis of survival [7].  Cancer metastasis is a multistep 
process in which the tumor microenvironment (TME) facilitates cancer cell-ECM interactions 
85
that are necessary for metastasis to occur [8].  The ECM in breast tumors is composed of a 
complex meshwork of fibrillar collagens, glycoproteins, and proteoglycans [9], which 
profoundly affect metastasis, as well as proliferation, angiogenesis, adhesion, migration, 
invasion, macromolecular transport, and drug delivery [9-13].  Multiple molecular mechanisms 
such as ECM degradation by proteases secreted by cancer cells, and dysregulated ECM synthesis 
by tumor-associated stromal cells have been implicated in the formation of the significantly 
altered ECM of breast tumors [8] that include structural changes in the fiber patterns of fiber-
forming ECM components.  Col1 fibers are the major structural ECM component in breast 
tumors [5, 6, 9, 14, 15], and increased stromal Col1 has been found to facilitate breast tumor 
formation, invasion, and metastasis [5, 6].  
X-ray mammography, which detects radiodense fibroglandular tissue in the breast, 
demonstrated that women with high (50% to 74% versus <5%) breast density have a 4.64-fold 
increased risk of developing breast carcinoma [16, 17].  Histologic evaluation of biopsy and 
mastectomy specimens from X-ray mammographically dense breast regions revealed a 
significantly higher collagen density and extent of fibrosis in these regions [14, 15].  High Col1 
fiber density significantly increased mammary tumor initiation, progression, and lung metastasis
[6].  Cancer cell invasion in this mouse model started at the tumor-stromal interface in the 
primary tumor along radially aligned Col1 fibers, which can form avenues for metastasis [5].  In 
a recent study, Col1 fibers that were oriented perpendicular to the cancer cell boundaries were 
found to serve as a prognostic signature for survival of breast carcinoma patients [7].
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Here we have, for the first time, performed a pilot study to test the relationship between 
lymph node metastasis and Col1 fiber texture and density in primary human breast cancers using 
second harmonic generation (SHG) microscopy.  SHG microscopy detects an intrinsic signal 
generated by the noncentrosymmetric physical properties of Col1 fibers, and does not require the 
use of an exogenous optical imaging agent [3, 4, 18].  We have performed a small retrospective 
SHG microscopy study to determine if the Col1 fiber signature in primary breast tumors is 
altered in patients presenting with lymph node metastasis compared to patients with uninvolved 
lymph nodes.  We used our in-house automated fiber analysis software as previously described 
[19], which is free of user variability and observed that primary breast cancers in LN+ patients 
have significantly denser Col1 fiber signatures than primary breast cancer in LN- patients.  To 
validate our in-house software results, we additionally used two commonly used texture analysis 
techniques to analyze Col1 images [20-22]: the gray level co-occurrence matrix (GLCM) and the 
Fourier transform (FT).  We observed that the GLCM parameters co-relation and energy and the 
FT parameters aspect ratio and eccentricity were significantly different for the Col1 fiber 
distribution in LN+ cases as compared to the LN- cases.  We also demonstrated that tissue 
fixation and paraffin-embedding had no effect on SHG Col1 fiber detection and quantification, 
indicating that Col1 fiber assessment by nondestructive SHG microscopy may be implemented in 
routine clinical pathology settings.  
Materials and Methods
Ethics Statement
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An exemption for retrospective analysis of de-identified human breast tumor specimens 
was approved by the Institutional Review Board of the Johns Hopkins University School of 
Medicine as these specimens were not collected specifically for this particular research project, 
and the identity of the individuals to whom the specimens pertain was unknown to everyone 
involved in this research project.  Research that involves only coded human biological specimens 
is not human subjects research under the human subjects regulations of the US Department of 
Health and Human Services.  
All experimental animal protocols were approved by the Institutional Animal Care and 
Use Committee of the Johns Hopkins University School of Medicine under the animal protocol 
number MO08M166 and under the Animal Welfare Assurance Number A3272-01.
Tumor Xenograft Specimens
To test if different types of tissue processing affect the SHG Col1 fiber signals, we used a 
xenograft model system of human breast tumors instead of valuable patient material.  MCF-7, a 
nonmetastatic, estrogen-sensitive (estrogen-dependent) line, was orthotopically inoculated in the 
upper left thoracic mammary fat pad of female athymic nude mice to grow breast tumor 
xenografts.  MCF-7 breast cancer cells were purchased from the American Type Culture 
Collection (ATCC) and used within 6 months of obtaining them from ATCC.  The MCF-7 cell 
line was tested and authenticated by ATCC by two independent methods: the ATCC cytochrome 
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C oxidase I PCR assay and short tandem repeat profiling using multiplex PCR.  For MCF-7 cell 
inoculations, 0.18 mg of a 60-???????????????-estradiol pellet (Innovative Research of America) 
was subcutaneously implanted near the left shoulder of athymic nude mice 1 week before 
inoculation.  Two million MCF-7 cells were inoculated in a volume of 0.05 mL HBSS (Sigma; 
no Matrigel was used).  Tumor size was about 500 mm3 when animals were sacrificed and 
tumors were removed.  To assess if tissue processing affects SHG-detected Col1 fiber patterns, 
each tumor was cut into three equal-sized parallel-cut pieces.  One piece was formalin-fixed 
paraffin-embedded (FFPE), a second piece of the same tumor was put on a microscope slide and 
kept in an ice-box for immediate fresh-tissue SHG imaging, and a third piece of the tumor was 
placed in Tissue Tek OCT freezing compound (Sakura Finetek USA, Inc, Torrance, CA), 
cryosectioned with a microcryotome (Microm International, Walldorf, Germany) at 100 μm
thickness, fixed with 4% paraformaldehyde (Sigma-Aldrich) solution, and mounted with 
Faramount aqueous mounting medium (DakoCytomation, Carpinteria, CA).
Breast Cancer Specimens
We retrospectively analyzed 14 breast cancer tissues, all of which were invasive ductal 
carcinomas (IDC).  Eight of these breast cancers were LN+ and 6 were LN-.  All cancers were 
tumor grade 2-3, estrogen receptor positive (ER+), and progesterone receptor positive (PR+).  
All of our samples were obtained from hospitals in Maryland and were graded by board-certified 
breast pathologists including Dr. Pedram Argani.  Snap-frozen primary breast tumor specimens 
were placed in Tissue Tek OCT freezing compound (Sakura Finetek USA, Inc, Torrance, CA), 
cryosectioned with a microcryotome (Microm International, Walldorf, Germany) at 100 μm
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thickness for whole mount sections and 5 μm thickness for adjacent sections, fixed with 4% 
paraformaldehyde (Sigma-Aldrich) solution, stained for nuclei with Hoechst 33342 (Invitrogen 
Corp, Carlsbad, CA), and mounted with Faramount aqueous mounting medium 
(DakoCytomation, Carpinteria, CA) as previously described [19].  For testing the within-tumor 
consistency of SHG-detected Col1 inter-fiber distances and Col1 fiber volume, we obtained 
FFPE samples from four different biopsy passes of the same breast cancer for four human 
specimens, which were grade 3, LN+, ER+, and PR+; grade 2, LN+, ER+, PR+; grade 2, LN-,
ER+, PR+; and grade 3, LN+, ER+, PR-.  These FFPE samples were embedded in paraffin 
blocks, within which they were marked with the pink dye phloxine, which visualizes the shape of 
the biopsy specimen within the white paraffin block.  We also obtained the adjacent H&E slide.  
In our pathology lab, the H&E section is always cut as the last slide in the series that is cut from 
a given FFPE block.  Therefore it was possible to spatially correlate the shape of the hematoxylin 
and eosin (H&E) section with the specimen in the FFPE block.   
SHG Imaging
SHG microscopy was performed on a Zeiss LSM 710 NLO Meta confocal microscope 
(Carl Zeiss MicroImaging, Inc, Thornwood, NY) equipped with a 680–1080 nm tunable 
Coherent Chameleon Vision II laser with automated pre-compensation (Coherent, Inc, Santa 
Clara, CA) located in the Johns Hopkins University School of Medicine (JHU SOM) Microscope 
Core Facility (directed by Dr. Scot Kuo).  Incident laser light of 880 nm was used for generating 
the SHG Col1 signal and laser light of 760 nm for two-photon excitation of Hoechst 33342.  The 
laser power used was about 10 mW for the 880 nm channel and about 19 mW for the 760 nm
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channel.  The SHG signal was detected within 410–450 nm, and the Hoechst fluorescence was 
detected within 400–475 nm.  Six to ten random fields of view (FOVs) per sample that were 
equidistantly spread throughout the breast tumor specimen were imaged to provide a realistic 
representation of each breast cancer sample.  At each FOV, we acquired a z-stack of 100 μm
total thickness with a z-interval of 5 μm using a 25x/0.8 LD LCI PlanApo multi-immersion lens.  
The corresponding images of adjacently cut H&E stained 5-mm thick sections were used to 
verify that all samples contained cancer.  Brightfield microscopy of the H&E-stained adjacent 
sections was performed using a Nikon inverted microscope equipped with a Nikon Coolpix 
digital camera (Nikon Instruments, Inc, Melville, NY).  For testing the within-tumor consistency 
using FFPE blocks of different biopsy passes, we additionally performed tile-function imaging 
covering the entire biopsy sample for two biopsy passes, again acquiring z-stacks of 100 μm
total thickness with a z-interval of 5 μm using the 25x lens.  
Col1 Fiber Quantification
To quantify our data independent of SHG signal intensity and free of errors introduced by 
user variability, we used automated geometric analysis and texture analysis techniques.  We used 
a geometric analysis technique, where the parameters of fiber volume and inter-fiber distance 
were calculated.  Image analysis to quantify the Col1 inter-fiber distance and the Col1 fiber 
volume was performed using in-house software as previously described [19].  This software was 
written in Matlab using MATLAB 7.4.0 (TheMathWorks, Natick, MA) and was previously 
described in detail [19].  Briefly, our software quantifies the median of all Col1 inter-fiber 
distances and the total Col1 fiber volume as outlined in Figure 1.  A representative z-plane of a 
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raw image is shown in Figure 1A, which is preprocessed to exclude noise and nonfibrillar shapes 
as demonstrated in the schematic in Figure 1B, resulting in the extraction of Col1 fiber structures 
from the raw images as shown in Figure 1C.  As indicated in Figure 1D, Euclidean distances 
from each empty voxel to the nearest Col1 fiber voxel were computed within each three-
dimensional FOV to quantify the inter-fiber distances and the total fiber volume from the Col1 
fiber mesh.  Based on a previous report, we expected more tightly packed Col1 fibers and a 
higher fiber volume for LN+ cases as compared to LN- cases [6].  Therefore, a one-sided t-????????
= 0.05) was used to detect significant differences in the Col1 inter-fiber distance and the Col1 
fiber volume between primary tumors from LN- versus LN+ cases using Microsoft Office Excel 
2007 (Microsoft, Redmond, WA).  P values of < 0.05 were considered to be significant.  P 
values of 0.10 > P > 0.05 were considered to be a trend towards significance [23].
To validate our analysis results, we also used well-established texture analysis methods 
for Col1 fiber quantification [20-22], to see if the Col1 fiber distributions were significantly 
different for the LN- and LN+ cases as observed in our geometric analysis.  We used the gray 
level co-occurrence matrix (GLCM) and Fourier transform (FT) texture analysis to analyze Col1 
fiber distributions.  Several textural features were extracted by GLCM, which is a statistical 
texture analysis method based on the second order statistics of an image’s gray scale histogram 
[24].  This analysis was done in in Matlab using MATLAB 7.4.0 (TheMathWorks, Natick, MA).  
The extracted features include: 1) Contrast, which is a measure of intensity variation, with a 
contrast = 0 for a constant image, and a range = [0 1]; 2) Co-relation, which is a measure of how 
a pixel is co-related to its neighboring pixel, with 1 for positively and -1 for negatively co-related 
pixels, and a range = [-1 1]); 3) Energy, which is also known as uniformity or angular second 
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moment, with an energy = 1 for a constant image, and a range = [0 1]; and 4) Homogeneity, 
which is a property measure of how homogeneous an image is, with a value = 1 for a constant 
image, and a range = [0 1] [25].  We also calculated the two-dimensional FT for all images.  For 
randomly distributed Col1 fibers the resulting FT approximates a circle, while for a more 
organized fiber pattern, the FT looks elliptical.  FT features were obtained by fitting an ellipse to 
the FT of each image and include: 1) Aspect ratio (AR), which is the ratio of the major axis to 
the minor axis of the ellipse; 2) Orientation, which is the angle between the x-axis and the major 
axis of the ellipse; and 3) Eccentricity, which is the ratio of the distance between the foci of the 
ellipse and the length of the major axis.  For a circle, the eccentricity is 0, and its range = [0 1].  
A one-sided t-???????????????????????????????????????????????????????????????????????????????????????
above parameters between primary tumors from LN- versus LN+ cases using Microsoft Office 
Excel 2007 (Microsoft, Redmond, WA).  P values of < 0.05 were considered to be significant.
Figure 1:  Construction of inter-fiber distance and fiber volume: (A) composite image of the Col1 fibers 
(red) and cell nuclei (green); preprocessing using the optional filter (B) to identify fiber-like objects (red) 
among various non-fiber-like objects in the image to produce (C) the corresponding Col1 fiber image; (D) 
computing the distances from each 3D voxel to the surrounding fibers in 3D to determine the nearest 
distance to a fiber in [μm] and the total fiber volume [%].  One z-plane from a 3D image stack is 
displayed in A and C.  Each image size is 339 μm x 339 μm.  The scale bars represent 50 μm.  
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Results
To test if the SHG microscopic detection of Col1 fiber signatures depends on tissue 
processing, we compared fresh tissue samples with formaldehyde-fixed, Hoechst-stained whole-
mount sections and with FFPE samples from the same MCF-7 breast tumor xenograft.  The data 
presented in Figure 2 demonstrate that SHG microscopy effectively revealed Col1 fiber 
signatures in this breast tumor xenograft model.  We found that the Col1 fiber distribution in 
tissues under these different preparations were fairly consistent.  Figure 2A-C shows that the 
Col1 fiber structures were stable and remained unaltered in the same MCF-7 breast tumor 
xenograft that was first imaged fresh, and from which adjacent sections were re-imaged after 
4%-paraformaldehyde-fixation and Hoechst 33342-staining, or after formalin-fixation and 
paraffin-embedding within FFPE blocks.  The Col1 fiber volume (Figure 2D) and inter-fiber 
distance (Figure 2E) from 5 randomly selected fields of views (FOVs) detected from each 
sample preparation revealed no changes between the same tissue that was fresh, fixed, or 
paraffin-embedded.  These results suggest that tissues with different preparations (fresh, fixed, or 
FFPE) can be used for SHG-Col1 imaging studies without introducing artifacts, although in 
practice, tissue processing within each experimental set-up should be kept consistent to avoid 
any potential variations across different types of tissue preparations.  
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Figure 2: The SHG signal is robust and independent of tissue processing.  We obtained comparable 
images from (A) fresh, (B) fixed and Hoechst-stained, and (C) paraffin-embedded MCF-7 breast tumor 
xenograft tissue, consistent with (D) almost identical results obtained by fiber volume and (E) inter-fiber 
distance quantification of 5 randomly selected fields of views (FOVs) from each differently processed 
tissue.  Each image size is 339 μm x 339 μm.  The scale bars represent 50 μm.  
We compared the Col1 fiber signatures in the primary tumors of LN- and LN+ patients in 
an initial proof-of-principle pilot study.  As evident in Figure 3, denser SHG Col1 fiber 
signatures were detected in primary tumor specimens from 8 LN+ patients compared to those 
from 6 LN- patients.  We quantified 10 randomly selected, equidistant FOVs from each primary 
tumor to assess global Col1 changes.  This approach accounts for the possibility that Col1 fiber 
architecture can be spatially heterogeneous within a given tumor.  The image quantification 
software described above was used to quantify the Col1 fiber volume (Figure 3C) and distance 
(Figure 3D) in this geometric analysis.  The Col1 fiber volume significantly (p=0.0036, n=6-8, 
values are mean+standard deviation) increased from 20.33 x 5.56% in LN- to 29.22 ± 4.72% in
LN+ patients.  The Col1 inter-fiber distance showed a trend towards significance (p=0.0807, 
n=6-8, values are mean+standard deviation) and decreased from 2.88 x 1.07 μm in LN- to 2.25 ±
0.45 μm in LN+ patients (Figure 3).  The primary tumors of all patients were positive for 
estrogen receptor (ER) and progesterone receptor (PR).  Hence ER and PR status were the same 
in all patients and were not confounding factors in this comparison. 
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Figure 3: Primary breast tumors from LN+ patients contained denser Col1 fibers than primary tumors 
from LN- patients.  Shown are representative SHG Col1 fiber (red) images from a (A) LN- patient and a 
(B) LN+ patient.  Nuclei were counterstained with Hoechst (green).  Each image size is 339 μm x 339 
μm, one z-plane is displayed.  The scale bars represent 50 μm.  LN- patients (n=6) displayed (C)
significantly (p=0.0036) decreased fiber volume and (D) and a trend (p=0.0807) toward increased inter-
fiber distance compared to LN+ patients (n=8).  Values are mean ? standard deviation.
To validate our geometric analysis of the differences observed in Col1 fiber distribution 
of LN- versus LN+ patients, we used different texture analysis methods to quantify the fiber 
patterns in a manner that is independent of the SHG signal intensity.  We analyzed the same 
FOVs as used for the geometric analysis using GLCM and FT methods.  We observed that the 
GLCM parameters co-relation and energy (Figure 4A) significantly separated the LN- and LN+ 
patients (p=0.0007 and p= 0.01788, respectively).  The Col1 fibers in LN- samples had a 
significantly lower co-relation (LN- mean=0.44, LN+ mean=0.67, p=0.0007) and a significantly 
higher energy value (LN- mean=0.47, LN+ mean=0.28, p=0.01788) as compared to the fibers in 
LN+ samples.  These parameters of higher co-relation and lower energy in LN+ versus LN-
cases indicate that LN+ samples had more and denser Col1 fibers than LN- samples, which is 
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consistent with our geometric analysis results.  In Figure 4B, we show that the FT parameters 
aspect ratio (AR) and eccentricity were significantly different for the LN- and LN+ patient 
samples (p=0.0557 and p=0.0462, respectively).  The LN- samples had a significantly higher AR 
(LN- mean=1.9, LN+ mean=1.45, p=0.057) and a significantly higher eccentricity (LN-
mean=0.74, LN+ mean=0.66, p=0.0462) as compared to the LN+ samples.  The FT analysis 
parameters AR and eccentricity were able to distinguish between LN+ and LN- samples.  
However, because the spatial information is lost in FT analysis, it was not possible in our case to 
interpret the decrease in AR and eccentricity in LN+ versus LN- patients in terms of geometric 
fiber parameters. 
To assess if local Col1 fiber differences in a given tumor affect global Col1 fiber 
measurements obtained by analyzing and quantifying 10 randomly selected, equidistant FOVs 
from each primary tumor (N=14), we determined the spatial heterogeneity of the Col1 fiber 
architecture in breast tumor specimens.  This assessment is necessary because with microscopic 
techniques, such as SHG Col1 fiber imaging, the FOV is in the range of hundreds of microns, 
while clinical breast tumors typically span larger diameters.  Therefore, it is necessary to test if 
the differences in Col1 fiber density globally span the tumor, or are local phenomena.  Our data
presented in Figure 5 show that the Col1 inter-fiber distance distribution and fiber volume are 
almost identical in four biopsy passes that were obtained from the same human breast tumor 
specimen.  In addition, the overall averages of a Col1 fiber volume of 25 ± 3% and distance of 
3.0 ± 0.4 μm for the tile-imaged biopsy pass B1 are comparable to the averages from 6 FOVs per 
biopsy pass (Figure 5).  Comparable results were obtained for a total of four primary breast 
tumor cases, where the Col1 fiber volumes and inter-fiber distances for six equidistant FOVs 
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from four separate biopsy passes from each one of the four tumors gave comparable results (null 
hypothesis of the T-test was true, i.e. p-value >0.05 for all breast tumor cases; N=4).  While there 
is some heterogeneity in the Col1 fiber architecture in breast tumor specimens, our approach of 
measuring and averaging over several randomly selected, equidistant FOVs that cover the entire 
tumor/biopsy averages out local fiber heterogeneity and detects overall global changes in Col1 
fiber signature.  Our data indicate that global Col1 fiber alterations in breast tumors dominate 
local Col1 fiber differences.
Figure 4: GLCM and FT texture analyses of Col1 fibers in primary breast tumors were able to 
distinguish between LN+ and LN- patients.  (A) GLCM parameters showed that LN- patients (n=6) 
displayed a significantly decreased inter-fiber co-relation (p=0.0007) and significantly higher energy 
uniformity (p=0.0178) as compared to LN+ patients (n=8).  Texture analysis using FT demonstrated that 
(B) the Col1 fiber distribution of LN- patients (n=6) had a significantly higher aspect ratio (AR, 
p=0.0572) and significantly higher eccentricity value (p=0.0462) as compared to LN+ patients (n=8).  
Values are mean ? standard deviation.
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Figure 5:  (A) SHG tile imaging covering breast tumor biopsy B1 and (B) the adjacent hematoxylin and 
eosin stained section.  (C) Fiber Volume and (D) Fiber Distance were quantified with our software on a 
FOV by FOV basis covering the entire biopsy pass B1 to visualize the spatial heterogeneity by heat maps.  
Representative, average fiber volume and inter-fiber distance of the 3D data stack is displayed in 2D (C 
and D).  Six randomly selected FOVs (marked in red/black) in this biopsy were analyzed for their Col1 
fiber distribution.  Four biopsy passes B1 (shown), B2, B3, and B4 taken from the same LN+ breast 
tumor were analyzed for their Col1 fiber (E) volume and (F) distance and displayed close to identical 
values for both parameters.  Values are mean ? standard deviation.  These findings demonstrate that 
robust global changes in Col1 fiber architecture occur in malignant breast tumors, which can be reliably 
quantified by randomly selecting six FOVs.  Each image size is 9862 μm x 4080 μm.  The scale bars 
represent 500 μm.
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Discussion
The presence or absence of metastases in axillary lymph nodes is currently the most 
important predictor of prognosis in breast carcinoma, and an integral component of the breast 
cancer staging system [26, 27].  Using ex vivo primary tumor specimens from patients, we 
observed increased Col1 fiber density in LN+ compared to LN- patients (p=0.0036, N=14) and 
significantly varied fiber distributions as obtained by our texture analysis (correlation, p=0.0007; 
energy, p=0.0179; AR, p=0.0557; eccentricity, p=0.0462; N=14).  Our data are in good 
agreement with a recent study that identified a tumor-associated Col1 signature (TACS) of 
bundles of straightened and aligned Col1 fibers that are oriented perpendicular to the tumor 
boundary as an independent prognostic marker for poor survival in patients with this TACS in 
their primary tumors [7].  While this larger clinical study scored for disease-free survival in 196 
patient samples on human breast carcinoma tissue microarrays, our study more specifically 
compared primary tumors from LN+ and LN- patients in an initial proof-of-principle study.  
Unlike the study by Conklin et al. [7] that relied on a qualitative yes-no judgment performed by 
trained persons without software involvement or quantification, data analysis in our study was 
done by an in-house automated software that quantifies inter-fiber distance and fiber volume 
from raw Col1-SHG images.  A major advantage of this automated analysis approach is that it is 
free of errors from subjective judgement, and that it can give quantitative results in real-time.  By 
averaging over [6-10] FOVs that were equidistantly spread throughout each breast tumor 
specimen, we were able to obtain robust quantitative results (N=14, total number of tissue 
samples).  Our data are also in good agreement with preclinical findings in a bi-transgenic mouse 
model, in which high Col1 fiber density promoted mammary tumor initiation, progression, and 
metastasis [6], and provide the first patient data linking lymph node metastasis with Col1 fiber 
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density.  In addition, recent studies demonstrated that high Col1 fiber density in primary tumors 
can facilitate metastasis by providing dense Col1 fiber avenues along which cancer cells migrate 
to ultimately establish distant colonies [5, 6].  In these studies the initial invasion of breast cancer 
cells at the tumor-stromal interface was shown to occur along radially aligned Col1 fibers in the 
primary tumor [5, 6].  Breast cancer cells invade into Col1 matrices by overexpressing integrins 
on their cell surface, which enable these cells to adhere to the Col1-containing ECM [28, 29].
Cancer cells migrate through lymphatic vessels to the connected sentinel lymph node to establish 
metastatic growth [30-33].  Since lymphatic vessels are attached to collagen through anchoring 
filaments [34-36], future studies should focus on identifying if Col1 fibers guide migrating 
cancer cells into tumor-associated lymphatic vessels within the primary tumor.  
In the clinic, the lymph node status is typically assessed by a sentinel lymph node biopsy, 
where the ‘sentinel nodes’ draining the lymphatic basin containing the tumor are identified and 
excised.  This biopsy is typically performed at about 3 weeks after the initial breast biopsy [27]
to identify and histologically examine axillary lymph nodes that are at high risk of containing 
cancer cells [27].  There is a 25% adverse event rate after sentinel lymph node biopsy, with 9% 
of patients having axillary paresthesia, 6% having lymphedema, 6% having axillary seromas, and 
3% having wound infections [27].  Avoiding the sentinel lymph node biopsy procedure would 
eliminate these risks for those patients that are LN-.  If the sentinel lymph nodes cannot be 
identified, additional axillary lymph node dissection is performed, which causes even more 
adverse surgical effects than the sentinel lymph node biopsy alone [27].  Therefore, novel 
biomarkers that alone, or when integrated with other standard markers, accurately predict for 
lymph node metastasis are critically needed.  Our data suggest that SHG imaging of Col1 fibers 
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may serve as a surrogate marker to predict the presence of lymph node metastasis, which is in 
good agreement with the study by Conklin et al. [7] that showed that a specific TACS was able 
to predict survival.  Col1 fibers were detected by optical second harmonic generation (SHG) 
microscopy, a highly sensitive and non-destructive technique that images intrinsic signal from 
Col1 fibers [4, 18, 37, 38].  Several other breast cancer markers have been associated with 
axillary lymph node metastasis such as CCND1, CD44, COX-2, EGFR, HER2/NEU, HPA, and 
LYVE-1 (reviewed in [39]).  In addition, increased expression of vascular endothelial growth 
factor-C (VEGF-C) or VEGF-A, both of which are able to promote lymphangiogenesis in 
primary tumors, correlated with an increased incidence of regional lymph node as well as distant 
metastases in humans and animals [30-32].  Different techniques assessing protein expression, 
mRNA expression, chromosome alterations, and DNA copy number changes are being used to 
evaluate these markers of lymph node metastasis in primary breast tumors [39].  The advantage 
of SHG-detection of Col1 fibers as a biomarker of lymph node metastasis is that the technique is 
non-destructive and can be used to interrogate live tissues.  
Our data show that the global Col1 fiber architecture in a given breast cancer is an 
important parameter, which dominates local Col1 fiber differences within the tissue.  Our 
approach of probing several randomly selected, equidistant FOVs covering the entire 
tumor/biopsy to average out local fiber heterogeneity ensures that we are measuring global Col1 
fiber architecture, which is quantified by the parameters Col1 fiber volume and inter-fiber 
distance.  We previously observed in an orthotopic human breast tumor xenograft model that 
hypoxic tumor microenvironments reduce Col1 fiber density and increase Col1 inter-fiber 
distance [19].  Some of the occurring local heterogeneity in the Col1 fiber architecture of human 
102
breast cancers may be due to hypoxic regions in these tumors.  To implement SHG microscopy 
of Col1 fibers in the breast pathology work-flow, it would be feasible to image the SHG Col1 
fiber signatures using paraffin blocks generated from excised tumors of patients as was done in 
Figure 3 or from biopsies as shown in Figure 5.  As SHG microscopy is non-destructive, the 
unaltered paraffin blocks can be returned to the pathology archive following SHG microscopic 
investigation.  Another major advantage of SHG microscopy is that it can be performed through 
an ultra-compact fiber-optic endomicroscope [40-45], which can be integrated with a 14-gauge 
breast biopsy needle.  Such “through-needle” SHG endomicroscopy may in the future allow for 
SHG Col1 imaging to be performed during the initial diagnostic mammography-guided breast 
biopsy in the clinic.  We have also demonstrated the feasibility of using automated software to 
analyze Col1 fibers, and obtain robust quantitative results that avoid human subjectivity and 
error.  Our software has the potential to provide real-time results during fiber-optic 
endomicroscopy scanning.
Col1 fibers are the target of recently developed stromal depletion therapies to treat 
desmoplasmic tumors [46].  Stromal depletion therapies are currently going into clinical trials in 
pancreatic cancer [46].  Imaging biomarkers that are able to assess the response to such therapies 
in patients will be important.  The SHG-detected Col1 fiber signature may provide such a 
monitoring tool for stromal depletion therapies in the future, and this may be realized either by 
non-destructive SHG microscopy during the pathology work-flow using FFPE blocks, or by 
using SHG endomicroscopic imaging of Col1 fibers in patients.  Col1 fibers also play an 
important role in drug delivery across the ECM of tumors, for which SHG imaging can serve as 
an assessment tool [18].  Tumor delivery of nanotherapeutics may in fact be improved by 
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strategies aimed at reducing the Col1 fiber matrix, as recently demonstrated with a Col1 
synthesis inhibitor in desmoplasmic models of human breast, pancreatic, and skin tumors using 
SHG microscopy [47].
Conclusions
In summary, the results obtained here have identified a potential biomarker that may be 
useful in the assessment and staging of breast cancer, and confirmed the importance of Col1 
fibers in the metastatic process.  Larger scale studies using breast and other cancer tissues are 
necessary to validate the sensitivity and specificity of Col1 fibers detected with SHG microscopy 
to predict the presence of cancer cells in lymph nodes.  Such studies can lead to the development 
of an imaging biomarker to evaluate lymph node metastasis at the time of presentation, and may 
result in the formulation of novel Col1 fiber-depletion strategies to reduce metastatic spread.  
Detection and quantification of Col1 fibers can easily be implemented in clinical pathological 
laboratory routines to provide additional valuable information for potentially predicting lymph 
node involvement in breast cancer.  Automated software can be used to quantify the Col1 fiber 
distribution to give objective results, with the potential to perform real-time quantification during 
endomicroscopy.
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Abbreviations footnote
Albumin-GdDTPA, albumin-Gd-diethylenetriaminepentaacetate
Col1, collagen 1
ECM, extracellular matrix
FOV, field of view
FCM, fuzzy c-means 
HIF, hypoxia inducible factor
HRE, hypoxia response element
K-S, Kolmogorov-Smirnov
MMCA, macromolecular contrast agent
MRI, magnetic resonance imaging
PS, permeability surface area product
RFP, red fluorescent protein
ROI, region of interest
SCID, severe combined immunodeficient
SHG, second harmonic generation
SD, standard deviation
VV, vascular volume
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Abstract
Hypoxic tumor microenvironments result in an aggressive phenotype and resistance to 
therapy that leads to tumor progression, recurrence, and metastasis.  While poor vascularization 
and the resultant inadequate drug delivery are known to contribute to drug resistance, the effect 
of hypoxia on molecular transport through the interstitium and the role of the extracellular matrix 
(ECM) in mediating this transport are unexplored.  The dense mesh of fibers present in the ECM 
can especially influence the movement of macromolecules.  Collagen 1 (Col1) fibers form a key 
component of the ECM in breast cancers.  Here we characterized the influence of hypoxia on 
macromolecular transport in tumors, and the role of Col1 fibers in mediating this transport using 
an MDA-MB-231 breast cancer xenograft model engineered to express red fluorescent protein 
under hypoxia.  Magnetic resonance imaging of macromolecular transport was combined with 
second harmonic generation microscopy of Col1 fibers.  Hypoxic tumor regions displayed 
significantly decreased Col1 fiber density and volume, as well as significantly lower 
macromolecular draining and pooling rates, than normoxic regions.  Regions adjacent to severely 
hypoxic areas revealed higher deposition of Col1 fibers and increased macromolecular transport.  
These data suggest that Col1 fibers may facilitate macromolecular transport in tumors and their 
reduction in hypoxic regions may reduce this transport.  Decreased macromolecular transport in 
hypoxic regions may also contribute to poor drug delivery and tumor recurrence in hypoxic 
regions.  High Col1 fiber density observed around hypoxic regions may facilitate the escape of 
aggressive cancer cells from hypoxic regions.    
116
Introduction
Tumors display abnormal physiological environments such as hypoxia, which primarily 
arise from their abnormal and chaotic vasculature [1].  Hypoxia is associated with increased 
resistance to radiation and chemotherapy, and with a more aggressive phenotype [1].  The 
discovery of the hypoxia inducible factor (HIF), and the identification of hypoxia response 
elements (HREs) as transcriptional controls in multiple genes [2], is continuing to unravel the 
critical role of hypoxia in influencing cancer progression and metastasis.  The molecular 
mechanisms underlying the cascade of changes induced by hypoxia and the HIF-axis have 
attracted significant attention [2], but the functional impact of hypoxia on the tumor extracellular 
matrix (ECM) and on the transport of macromolecules in the tumor interstitium is relatively 
unexplored.  Our purpose here was to investigate the role of hypoxia in altering the ECM, 
particularly the Col1 fiber distribution, and its effect on macromolecular transport.  To study the 
relationship between hypoxia, macromolecular transport, and Col1 fiber distribution, we 
combined dynamic magnetic resonance imaging (MRI) of the macromolecular contrast agent 
(MMCA) albumin-GdDTPA, to detect interstitial macromolecular transport, with second 
harmonic generation (SHG) microscopy to measure Col1 fibers morphology and distribution.  
SHG is a nonlinear optical process that requires a molecular environment without a center of 
symmetry, such as an interfacial region, to produce a signal that can be used to image 
endogenous structural proteins such as Col1 [3].  These studies were performed in MDA-MB-
231 human breast cancer xenografts genetically engineered to express tdTomato red fluorescent 
protein (RFP) under control of HRE [4].  
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As an abundant stromal component, Col1 fibers form a major part of the breast tumor ECM [5-
8].  Malignant breast cancers are characterized by significantly higher Col1 fiber density and 
altered Col1 fiber architecture [8].  High mammary Col1 density was shown to cause mammary 
tumor initiation, progression, and metastasis [8].  We have previously shown that hypoxic 
regions in breast and prostate tumor xenografts contain significantly lower Col1 fiber density and 
volume compared to normoxic tumor regions [9].  Hypoxia stimulates the gene expression of a 
cluster of hydroxylases necessary for Col1 fiber formation [10].  Hypoxic environments in 
tumors may lead to abnormal collagen deposition either by cancer cells or fibroblasts within the 
tumor stroma [8,11].  In normal tissue, Col1 fibers direct interstitial fluid into lymphatic channels 
[12].  In tumors, these fibers may not be structured for efficient flow of fluid, especially in 
hypoxic areas [9].  Here, by careful co-registration of in vivo MRI to ex vivo optical images, we 
related macromolecular transport to Col1 fibers morphology and hypoxia.  Macromolecules that 
extravasate from the vasculature into the tumor interstitium, are transported through the ECM 
either by diffusion or convection [13-15].  To understand drug delivery through the tumor ECM, 
it is important to understand the role of both, Col1 fibers and hypoxia in this transport.
The movement of macromolecules through the ECM can also provide insight into the 
movement of metastatic cells through the ECM.  Our data suggest that collagen fibers mediate 
macromolecular transport that is reduced in hypoxic low Col1 fiber containing regions.  Around 
these severely hypoxic regions, a dense Col1 fiber mesh is observed that aligns with increased 
macromolecular transport.  These results have significant implications for the delivery of 
macromolecular therapeutic agents as they uncover a new aspect of hypoxic environments in 
limiting macromolecular transport.  The sparser fibers within severely hypoxic regions and the 
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previously observed close correlation between dense collagen fibers and metastasis [16] suggest 
that the stimulus for invasion may occur from hypoxic environments with the denser collagen 
fibers around these regions providing avenues of escape and dissemination in the metastatic 
cascade. 
Materials and Methods
Ethics statement
All experimental animal protocols were approved by the Institutional Animal Care and 
Use Committee of the Johns Hopkins University School of Medicine under the animal protocol 
number MO11M122 and under the Animal Welfare Assurance Number A3272-01.
Tumor model and inoculation
The triple-negative metastatic human breast cancer cell line MDA-MB-231 [17] was 
obtained from the American Type Culture Collection (ATCC, Rockville, MD).  To generate 
MDA-MB-231 cells that express red fluorescent protein (RFP) under hypoxic conditions, MDA-
MB-231 cells were stably transfected with a construct containing five copies of the HRE of the 
human VEGF-A gene ligated to the cDNA of the tdTomato RFP, which produced MDA-MB-
231-5HRE-TdTomato cells as previously described and validated [4,18].  Two million MDA-
MB-231-5HRE-TdTomato cells were orthotopically inoculated in the right upper thoracic 
mammary fat pad of anesthetized female severe combined immunodeficient (SCID) mice.  
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MDA-MB-231-5HRE-TdTomato tumor xenografts reached their final experimental size of 
approximately 400-500 mm3 within 8 weeks and the studies were performed with 10 mice.
MRI acquisition 
Mice were imaged 8 weeks post inoculation, once tumor volumes were approximately 
400-500 mm3.  The mouse was anesthetized for MRI, and a home-built catheter was inserted in 
the tail vein to deliver the MMCA albumin-GdDTPA.  MRI was performed on a 4.7T Bruker 
spectrometer using a home built solenoid coil placed around the tumor.   The respiration rate was 
monitored and an isoflurane mask used to maintain stable anesthesia during the 123 min of MRI 
scan time.  The MRI acquisition was performed as previously described [19].  Briefly, multi-
slice relaxation rates (T1-1) were acquired using a saturation recovery technique with fast-T1 
SNAPSHOT FLASH imaging (flip angle = 10 degrees, echo time = 2 ms).  Images of the central 
4 slices (slice thickness of 1 mm) of the tumor were acquired (128 x 128 matrix, 16 mm field of 
view, number of average = 8) for three relaxation delays (100, 500 and 1000 ms).  A multislice 
map of completely relaxed magnetization (M0 map) was also acquired with a recovery time of 
seven seconds.  The in-plane resolution of the MR images was 125 μm x 125 μm.  Interstitial 
transport parameters were measured from quantitative T1 maps obtained before and following 
intravenous administration of the MMCA albumin-GdDTPA (500 mg/kg dose).  Images were 
acquired in two “phases” corresponding to the biphasic kinetics of the MMCA [19].  The “early 
phase” acquisition images included a pre-contrast image, and a 3 minute post-contrast image that 
was repeated every 5 minutes over the initial 30 minutes to characterize the tumor vascular 
volume (VV) and permeability surface area product (PS).  Since drainage of macromolecules in 
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and around tumors either by convection or by the lymphatics is a slow event, the second block of 
MR data was acquired up to 123 minutes post-contrast and was used to characterize the 
interstitial transport parameters through the ECM.  Transport parameters calculated included 
number of draining and pooling voxels, draining and pooling rates, and exudate volumes derived 
as previously described [19] and briefly described in the Quantification section).  At the end of 
the MRI acquisition, blood T1 was determined from 20 microliters drawn from the tail vein.  The 
experimental workflow is outlined in Figure 1.  
Fluorescence and multiphoton microscopy
Following the MRI acquisition, mice were euthanized and the tumors were excised.  The 
orientation of the tumor in the MRI scanner bore was registered using spatial markers, and the 
tumor sliced into 1 mm thick sections.  Optical imaging of the fresh tissue slices corresponding 
to the MR-imaged slices was performed to detect hypoxic and normoxic regions.  First an 
overview of the entire tumor slice was acquired at 1× magnification using a Nikon inverted 
microscope equipped with a Nikon Coolpix digital camera (Nikon Instruments, Inc., Melville, 
NY, Figure 1, Image acquisition block – Ex-vivo imaging).  Images of all four slices were 
acquired in the bright field for tissue architecture and in the red fluorescence field for detection 
of hypoxic regions.  Optical images acquired with the 1× objective, were used to map the MRI 
data to hypoxic and normoxic regions within the corresponding slices, and identify fields of view 
(FOV) to image Col1 fibers at higher magnification.  We used multiphoton microscopy to detect 
the SHG signal from the Col1 fibers in these fresh tissue slices.  SHG imaging was performed as 
previously described [9, 16].  Briefly, we used a 25×/0.8 LD LCI PlanApo multi-immersion lens 
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on a Zeiss 710 LSM NLO Meta multiphoton microscopy system (Carl Zeiss MicroImaging, Inc, 
Thornwood, NY) equipped with a 680-1080 nm tunable Coherent Chameleon Vision II laser 
(Coherent, Inc, Santa Clara, CA) with automated pre-compensation and fast scanning at 40 nm/s.  
3-dimensional (3D) image stacks were acquired from various fields of view (FOVs) in the 
hypoxic and normoxic regions.  Hypoxic FOVs were selected to contain more than 80% of red 
fluorescing cells and were therefore severely hypoxic.  Normoxic FOVs contained less than 1% 
of red fluorescing cells.  Col1 fibers were illuminated with incident laser light of 880 nm and 
detected at 410-470 nm.  The fluorescence from TdTomato red was excited at a wavelength of 
543 nm, and detected at 570-620 nm [9].  
Quantitative image analysis
Macromolecular transport in tumors was quantified from the dynamic MRI images based 
on biphasic kinetics of the MMCA as previously described [19].  Vascular VV and PS were 
calculated from the first 30 minutes during the ‘early phase’.  ‘Late phase’ images acquired up to 
123 minutes post contrast injection gave macromolecular transport parameters that included 
draining rate, draining volume, pooling rate, and pooling volume.  During the ‘late phase’ a 
draining voxel was defined as a voxel from which the contrast agent at a rate lower than the PS, 
and a pooling voxel was one in which the contrast agent concentration increased at a rate higher 
than the PS.  After identifying the draining and pooling voxels, the rates and exudate volumes 
were calculated.  All quantification analysis was done in a home-built program written in IDL 
(ITT Exelis Visual Information Solutions, VA USA) and AFNI (NIH software). 
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The structural information of the tumor microenvironment was obtained by quantifying 
the Col1 fiber distribution acquired with SHG microscopy.  Col1 fiber distribution analysis was 
performed as previously described [9].  Briefly, the inter-fiber distance and percent fiber volume 
present in hypoxic and normoxic FOVs were quantified.  The quantification of the Col1 fiber 
distance distribution and fiber volume was performed using a customized program written in 
Matlab (MATLAB 7.4.0, The MathWorks, Natick, MA).  Regions of interest (ROIs) containing 
more than 80 % of red fluorescing cells, considered severely hypoxic, and regions with less than 
1 % of red fluorescing cells, considered normoxic, were analyzed [9].  A two-sided paired t-test 
??? ?? ?????????? ????? ??? ??????? ???????????? ???????????? ??? ?????-fiber distances and percent fiber 
volumes between these severely hypoxic and normoxic ROIs using Microsoft Office Excel 2010 
(Microscoft, Redmond, WA).  P-values of < 0.05 were considered to be significant.
To combine functional and structural information, MRI and 1× optical images were co-
registered (Figure 1, Image processing and quantification block) to calculate transport parameters 
in hypoxic and normoxic ROIs.  To account for tissue deformation and differences in spatial 
information we used a mutual information – based registration approach and calculated Dice 
similarity statistics to quantify the quality of the co-registration.
To preserve the orientation of the tumor during the in vivo MRI acquisition, we used 5% 
agarose gel to cover the entire tumor, and made asymmetrical cuts in the surrounding agarose gel 
before acquiring the MRI images.  Since agarose gel contains water, it results in a uniform signal 
around the tumor in the M0 map (Figure 1, Image Acquisition block).  The asymmetrical 
markings were visible in the MRI images and helped mark the orientation of the tumor.  
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Following MRI, the tumor was excised and sliced with the tumor orientation maintained as it 
was in the MRI scanner.  For each modality we combined the various images acquired, extracted 
features, and used the mutual information approach for co-registration between modalities 
(Figure 1, Image Processing block).  For the MRI images we used the R1 maps acquired over 26 
time points to identify cluster features using the fuzzy c-means (FCM) [20,21] clustering 
technique (Figure 1, Image Processing block).  For the optical images, we fused the bright field 
and fluorescent images by wavelet based image fusion [22], and extracted features for the optical 
images using FCM.  Extracted features from the optical images were then registered to the 
extracted features from the MR image using affine transformation [23].  Rigid-body registration 
was used to avoid any feature distortion. Since the bright field image and fluorescence field 
image are intrinsically registered to the fused image, the same transformation matrix was applied 
to register them to the MR images.  Dice similarity index [24] was calculated to asses the 
registration error.  Dice similarity indices ranged from 0 to 1, where 0 indicates no overlap and 1 
indicates complete overlap [24].  For multimodality co-registration of in vivo MRI and ex vivo
optical data, a Dice similarity index > 0.85 was considered as good overlap.  Once the images 
were co-registered, the hypoxic regions were drawn out on the co-registered fluorescent images 
to calculate the vascular parameters of VV and PS in the hypoxic and normoxic regions.  
Similarly, the macromolecular transport parameters of draining rate and volume, and pooling rate 
and volume were calculated for hypoxic and normoxic regions (Figure 1, Image processing and 
quantification block – Quantification).  The co-registration and co-localization analysis was 
performed in MATLAB 7.4.0 (The MathWorks, Natick, MA).  A two tailed t-test was performed 
using Microsoft Office Excel 2010.  P-values of < 0.05 were considered to be significant (N = 
10).
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Figure 1: Workflow of the experimental design.  The workflow consisted of three distinct parts: image 
acquisition, image processing and image quantification.  For the image acquisition part, we performed in 
vivo MRI to extract functional information of vasculature and macromolecular transport within the tumor 
ECM.  Following MRI, the tumor was excised and ex vivo optical imaging performed to extract the 
distribution of hypoxic regions and Col1 fibers.  In image processing, MRI and optical images were co-
registered following which vascular and transport parameters in hypoxic and normoxic regions were 
computed.  Col1 fiber distributions in these regions were quantified to give fiber volume and inter-fiber 
distances.  For image quantification, the quantitative data were analyzed and comparisons performed 
between hypoxic and normoxic regions.
Results
Hypoxic regions were identified by tdTomato red fluorescence in the optical images (N = 
10, Figure 2a).  Using SHG microscopy, we observed significantly fewer and sparsely distributed 
Col1 fibers in severely hypoxic regions as compared to normoxic regions.  A 3D visualization of 
the Col1 fiber in these hypoxic regions (Figure 2b) and normoxic regions (Figure 2c) revealed 
that the regions in the sparsely distributed Col1 fibers were filled with hypoxic cells.  
Quantitative analysis of the Col1 fibers showed that the percentage of Col1 fiber volume in 
severely hypoxic regions was significantly lower than that in the normoxic regions (p-value = 
0.000106, N = 10, Figure 2d).  Similarly, the inter fiber distance in these hypoxic regions was 
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significantly greater than that in normoxic regions (p-value = 0.000121, N = 10, Figure 2e), 
indicating more sparsely distributed Col1 fibers in the hypoxic regions as compared to the 
normoxic regions.  
Figure 2: Optical imaging and quantification of fiber volume and fiber distribution.  (a) Ex vivo 1× bright 
field and fluorescence image overlaid showing the locations of hypoxic ROIs on the tumor section.  3D 
visualization of (b) hypoxic and (c) normoxic FOVs; hypoxic regions are displayed in red and Col1 fibers 
in green.  The FOV image size was 334.91 x 334.91 x 60 μm3 with a voxel size of 0.66 x 0.66 x 1 μm3.
(d) Hypoxic FOVs showed a significantly lower fiber volume as compared to normoxic FOVs (**p-value
= 0.000106, N = 10).  (e) Hypoxic FOVs have a significantly larger inter-fiber distance as compared to 
normoxic FOVs (* p-value = 0.000121, N = 10). 
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Figure 3: Co-registration results. (a) MR anatomical M0 images of the central four slices of the tumor as 
reference images (FOV = 16 x 16 x 4 mm3).  (b) Display of the optical bright field image overlaid with 
the fluorescence field image.  Features extracted from (c) MR images and (d) optical images, respectively.  
(e) Display of the extracted features from the MR images overlaid with the optical images after co-
registration.  (f) Registered optical bright field images overlaid with the fluorescence field images.  (g) 
The co-registration error represented by the Dice similarity index for all tumors (N = 10) in this study.
To understand how these differences in the Col1 fibers functionally affect molecular 
transport through the tumor ECM, the optical images were co-registered to the corresponding 
MR sections.  Figure 3a shows the M0 map of the central of four slices through the tumor; 
Figure 3b shows the corresponding fluorescence images overlaid on the bright field optical 
images before co-registration.  Figures 3c and 3d show the feature clustering from the MR 
images and the fused optical images (bright and fluorescence field images), respectively.  These 
extracted features were used to co-register the optical images to the corresponding MR sections.  
Figure 3e shows the extracted optical imaging features that were registered to the extracted MRI 
features.  The difference in color shows the error of registration mismatch between the MR and 
optical images.  Figure 3f shows the co-registered optical (fluorescence image overlaid with the 
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bright field images) and MR images.  The registration error between the MR and optical images
calculated as the Dice similarity index is shown in Figure 3g for all tumors.  The indices were 
greater than 0.85, indicating successful co-registration between the MRI and optical images.
From the co-registered optical and MR imaging data, we observed that red fluorescing 
hypoxic regions co-localized with regions where the VV was low, as shown by 3D 
reconstruction of all four slices of the optical and VV data of a representative tumor in Figures 
4a and 4b respectively.  We also observed lower PS in the hypoxic regions as compared to 
normoxic regions, as seen in Figure 4c.  We quantified these parameters and found that VV in 
hypoxic regions was significantly lower than that in normoxic regions (p-value = 0.000374, N = 
10, Figure 5a).  Similarly, PS values in the hypoxic regions were significantly lower than those 
in normoxic regions (p-value = 0.000215, N = 10, Figure 5b).  
Figure 4: Representative 3D reconstructed view of vascular parameters.  3D reconstruction of (a) optical 
image with hypoxic regions displayed in red within the tumor, (b) corresponding display of VV and (c) 
PS in a breast cancer xenograft. 
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Figure 5: Quantification results of vascular parameters.  Quantitative comparison of (a) VV and (b) PS 
for hypoxic and normoxic breast tumor regions.  Columns: Mean + standard deviation (SD).  We 
observed significantly lower VV (*p-value = 0.000374, N = 10) and PS (**p-value = 0.000215, N = 10)
in hypoxic regions compared to normoxic regions.  Columns: Mean + SD.
Representative 3D reconstructed optical images with the hypoxic regions displayed in red 
are shown in Figure 6a, along with the corresponding 3D molecular transport distributions of 
draining rate (Figure 6b), draining volume (Figure 6c), pooling rate (Figure 6d), and pooling 
volume (Figure 6e).  We observed that the draining (or efflux) rates in hypoxic regions were 
significantly lower than those in normoxic regions (p-value = 0.003221, N = 10, Figure 7a), and 
the draining volume was significantly lower in hypoxic regions as compared to that in normoxic 
regions (p-value = 0.001887, N = 10, Figure 7b).  Draining values are negative since the MMCA 
is leaving the voxel.  The pooling (or influx) rate in hypoxic regions was significantly lower as 
compared to that in normoxic regions (p-value = 0.000109, N = 10, Figure 7c), and the pooling 
volume was significantly lower in hypoxic regions as compared to that in normoxic regions (p-
value = 0.024693, N = 10, Figure 7d).
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Figure 6: Representative 3D reconstructed view of transport parameters.  3D re-construction of (a) the 
optical image as in 4a with hypoxic regions displayed in red within the tumor, (b) corresponding display 
of draining rate, (c) draining volume distribution, (d) pooling rate and (e) pooling volume distribution in a 
breast cancer xenograft.
Figure 7: Quantification of transport parameters.  Quantitative comparison of (a) draining rates, (b) 
draining volumes, (c) pooling rates and (d) pooling volumes.  We observed significantly lower draining 
rates (p-value = 0.003221, N = 10) and draining volumes (p-value = 0.001887, N = 10) in hypoxic regions 
as compared to normoxic regions.  We observed significantly lower pooling rates (p-value = 0.000109, N 
=10) and pooling volumes (p-value = 0.024693, N = 10) in hypoxic regions as compared to normoxic 
regions.  Columns: Mean + SD.
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Figure 8 shows the analysis of different tumor regions.  In Figure 8a, the 2D spatial 
distribution of VV and PS, draining rate (DR), draining volume (DV), pooling rate (PR), pooling 
volume (PV), optical bright field (OP_Bf), optical fluorescence field (OP_Fl) and fibers are 
shown for a representative tumor section in hypoxic (top panel), ~ 100 μm around hypoxic 
(middle panel), and normoxic (bottom panel) regions.  Figure 8b displays a representative SHG 
tile image scan with an enlarged inserts showing the Col1 fiber patterns adjacent to hypoxic 
regions.  This circular pattern around hypoxic regions was observed in most tumors.  As shown 
in Figure 8c, MMCA movement in regions adjacent to strongly hypoxic regions increased 
significantly (p-value = 0.014328) as compared to hypoxic regions.
Since chronic or acute hypoxia will ultimately result in cell death and necrosis if the 
tissue is not rescued by revascularization, it was important to establish that the differences in 
macromolecular transport between hypoxic and normoxic observed were not primarily due to 
severely hypoxic red fluorescing regions consisting of largely dying regions.  As shown in 
Figures 9a-c, red fluorescing regions contained viable cells.  Trends in macromolecular transport 
were similar irrespective of the extent of necrosis in these regions.  The presence of a ring of 
Col1 fibers around these red fluorescing regions (Figure 9d) is again confirmed in the magnified 
high-resolution tiled images shown in Figure 9e. 
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Figure 8: Regional Analysis. (a) Displays of the distribution of vascular parameters (VV, PS), transport 
parameters (DR – draining rate, DV – draining volume, PR – pooling rate, PV – pooling volume) and 
optical imaging parameters (OP_Bf – optical bright field, OP_Fl – optical fluorescence field, Col1 – Col1 
fibers) in hypoxic regions (top panel), ~ 100 μm around hypoxic regions (middle panel), and in normoxic 
regions (bottom panel) of a representative tumor section from a breast cancer xenograft.  (b) Tile scan of 
SHG microscopy of Col1 fibers of the same section, showing Col1 fiber patterns in the magnified inserts.  
(c) Quantifications of draining voxels in percent showing a significant increase (* p-value = 0.014329, N 
= 10) in percent draining area in areas surrounding hypoxic regions.
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Figure 9: Histological analysis.  (a) Hematoxylin and eosin (H&E) stained 5 μm thick  section from a 
representative tumor, (b) corresponding overlaid bright field and fluorescence field images showing the 
tdTomato red fluorescence hypoxic regions, (c) overlay of H&E section with fluorescence field image, (d) 
overlay of corresponding SHG tile scan of Col1 fibers with fluorescence field image, and (e) magnified 
inserts from (d) displaying the Col1 fibers encircling the hypoxic regions.
Discussion
Here, for the first time, we combined MRI with SHG microscopy to relate differences in 
collagen fibers between hypoxic and normoxic tumor regions to macromolecular fluid transport. 
Our purpose was to understand the role of hypoxia in modifying macromolecular fluid transport, 
using MRI, and collagen fiber distribution, using SHG microscopy.  Higher MMCA draining 
voxels were observed in normoxic regions which also exhibited a dense mesh of collagen fibers.  
In contrast there were few draining voxels in hypoxic regions which also exhibited fewer and 
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structurally altered collagen fibers.  These results suggest that collagen fibers may facilitate 
MMCA transport in tumors, for the size (~ 90 kDa) and charge of the agent used here, and their 
absence in hypoxic regions may reduce this transport.
For these studies, we developed an imaging pipeline to extract functional and structural 
information from the tumor microenvironment and quantify this information.  From the MRI 
results, we observed a heterogeneous distribution of VV, PS, draining rate and volume, and 
pooling rate and volume, which were consistent with previous observations [19].  Also consistent 
with previous observations, we observed that the Col1 fiber distribution was heterogeneous 
within the tumor [9].  In severely hypoxic regions the Col1 fiber volume was significantly lower 
and the Col1 inter-fiber distance was significantly greater as compared to normoxic regions as 
previously described [9].  
Since we used FCM features extraction and match features from MRI and optical 
imaging, it was necessary to validate the registration technique for these multimodality imaging 
data.  We therefore calculated the registration error using the Dice similarity index.  The 
registration was only considered acceptable for cases in which the Dice similarity index was 
greater than 0.85.  Both elastic and non-rigid registration [25, 26] were also evaluated.  However, 
in our case, the internal features were distorted by these techniques, which caused a loss of 
information as was evident from the low Dice similarity index.  We therefore used rigid affine 
transformation for the registration of the optical and MRI data, which resulted in an overlap of 
greater than 85% (N = 10) for the Dice similarity index.  Dice similarity index values of greater 
than 85% of overlap were considered successful for multimodality co-registration.  
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Higher MMCA draining rates and draining volumes were observed in normoxic regions 
that also exhibited a denser mesh of collagen fibers.  In contrast, there were lower draining rates 
and draining volume in hypoxic regions that also exhibited fewer and structurally altered 
collagen 1 fibers.  Higher MMCA pooling rate and pooling volume were observed in the 
normoxic regions as compared to the hypoxic regions.  These data suggest that hypoxic areas are 
like 'silent zones’ with very little movement of MMCA as detected by this method.  These data 
have significant implications in the transport of macromolecular therapeutic agents as they 
suggest that there is very little macromolecular trafficking in the ECM in hypoxic regions.  This 
is most likely a combination of the low vascular volume and permeability resulting in low 
delivery as well as the sparse collagen fibers that seem to mediate transport.  
In tumors such as pancreatic cancer, the dense mesh of Col1 fibers has been reported to 
act as a barrier to drug delivery, and Col1 depletion treatments are being developed to improve 
delivery [15, 27-29].  This fibrosis, which is typically observed in the desmoplastic stroma of 
pancreatic cancer, is very dense compared to what we observed in this human breast cancer 
xenograft model, and to what is typically observed in human breast cancers [16].  A Col1 fiber 
density of 25%, which we observed in normoxic regions, provides sufficient space for 
macromolecular transport, and in fact, our data suggest that these Col1 fibers act as guiding paths 
to the MMCA in the extracellular space.  Since we are measuring phenomena on different spatial 
scales, we cannot comment on the relationship between sub-voxel variations in Col1 density and 
the corresponding macromolecular transport.
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Immediately adjacent to the strongly hypoxic regions, a denser Col1 fiber network was 
observed together with increased macromolecular movement.  These data suggest that these 
fibers may provide avenues for opportunistic hypoxic cells, which have several invasive genes 
upregulated due to hypoxia, escaping from this hostile environment.  HIF stabilization under 
hypoxia transcriptionally activates several genes such as urokinase-type plasminogen-activator 
receptor (uPAR), matrix metalloproteinase-2 (MMP-2), autocrinemotility factor (AMF), 
transforming growth factor-?? ????-???? ?????????-D (CATHD), fibronectin 1 (FN1), keratin 14 
(KRT14), keratin 18 (KRT18), keratin 19 (KRT19), vimentin (VIM), c-MET tyrosine kinase that 
regulate invasion [2].  Col1 fibers have been shown to provide avenues for malignant cancer 
cells to travel along during their metastatic journey [7, 16, 30].  Cancer cells can rapidly traverse 
through tumors along linear Col1 fibers [30].  Since some of these fibers converge with blood 
????????? ????????????????? ?????????????? ??? ????????????????????????????? ? ? ???????????????????????
facilitate breast cancer cell attachment to Col1 fibers [31].  Provenzano et al.  [7] have observed 
that cancer cells travel along radially aligned Col1 fiber to metastasize and that more aggressive 
tumor types have characteristic tumor-associated Col1 structures (TACS).  The TACS classified 
as TACS 3 displays aligned Col1 fibers that are oriented perpendicular to regions of tumor cells, 
which are moving along these Col1 fibers as guiding paths for metastasis [7, 32].  A study with 
196 patients demonstrated that TACS 3 is described predictor of survival in human breast cancer 
patients [32].  It was also observed that the Col1 fiber density was 45% higher in lymph node 
positive (LN+ve) human samples as compared to the lymph node negative (LN-ve) tumor 
samples and the Col1 fiber distribution in the LN+ve patient samples was more densely packed 
than in the LN-ve patient samples [16].  The present study adds to an emerging picture that the 
136
stimulus for invasion and migration occurs from hypoxia, and the Col1 fibers provide avenues to 
escape from a hostile environment. 
In summary, we have co-registered and quantified in vivo MRI and ex vivo optical 
imaging data to obtain structural and functional information of the tumor microenvironment in a 
human breast cancer xenograft model.  These data highlight the importance of hypoxia and Col1 
fibers in macromolecular transport.  Further investigations into the role of the ECM and 
mechano-transduction pathways as well as cancer cell/fibroblast interactions and Col1 deposition 
under hypoxic conditions are merited to understand the role of the tumor microenvironment in 
ECM mediated drug delivery and metastasis.
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Collagen fibers mediate water diffusion and anisotropy
Manuscript in preparation
Collagen fibers influence water diffusion and anisotropy.
Samata M. Kakkad, Jiangyang Zhang, Alireza Akhbardeh, Desmond Jacob, Meiyappan 
Solaiyappan, Mike Jacobs, Venu Raman, Dieter Leibfritz, Kristine Glunde, Zaver M. Bhujwalla
142
Abbreviation footnote
2D, two-dimensional
3D, three-dimensional 
aDW, average diffusion weighted
ADC, apparent diffusion coefficient
Col1, collagen 1
DTI, diffusion tensor imaging
ECM, extracellular matrix
ER, estrogen receptor
FA, fractional anisotropy
FOV, field of view
H&E, hematoxylin and eosin
HER-2, human epidermal growth factor receptor 2
HIF-1, hypoxia inducible factor
HRE, hypoxia response element
IDC, invasive ductal carcinoma 
LN, lymph node
MRI, magnetic resonance imaging
PR, progesterone receptor
RFP, red fluorescent protein
SCID, severe combined immunodeficient
SHG, second harmonic generation 
VEGF-A, vascular endothelial growth factor A
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Abstract
Collagen 1 (Col1) fibers play an important role in macromolecular transport and cancer 
cell dissemination.  Our goal in this study was to understand the influence of Col1 fibers on 
water diffusion, and to examine the potential of using noninvasive diffusion tensor imaging 
(DTI) to detect Col1 fibers in breast lesions.  We have previously observed in genetically 
engineered human MDA-MB-231 breast cancer xenograft tumors that fluoresce under hypoxia
that fluorescing hypoxic regions contain relatively low amounts of collagen 1 fibers.  The same 
tumor model was used to further investigate the relationship between Col1 fibers, water diffusion 
and anisotropy, and hypoxia.  We observed for the first time that water diffusion and anisotropy 
followed the Col1 fiber distribution in human breast cancer specimens.  In regions with low Col1 
fiber content, apparent diffusion coefficient (ADC) and fractional anisotropy (FA) values 
decreased significantly as compared to regions containing dense Col1 fibers (p-value < 0.05).  In 
the breast cancer xenograft model, we observed that hypoxic regions with significantly lower 
Col1 fiber volume had significantly lower ADC and FA values as compared to normoxic tumor 
regions with higher Col1 fiber volume.  Lastly, we performed in vivo DTI measurements to 
confirm that DTI patterns in tumors observed in vivo spatially co-localized with DTI patterns 
observed ex vivo in the same tumors.  These studies have identified the potential use of 
noninvasive DTI as a biomarker to detect Col1 fiber density and further confirm the importance 
of Col1 fibers in molecular transport through the ECM.
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Introduction
Collagen 1 (Col1) fibers are a major structural component of the extracellular matrix of 
tumors [1].  Malignant breast cancers are characterized by significantly higher Col1 fiber density 
and an altered Col1 architecture [2].  Increased mammary Col1 fiber density was shown to cause 
mammary tumor initiation, progression, and metastasis [2].  Col1 fibers play an important role in 
macromolecular transport and cancer cell dissemination [3, 4].  Cancer cells travel along aligned 
Col1 fibers [4, 5], and tumor associated Col1 fiber alignment was identified to be a prognostic 
signature for survival in breast cancer patients [6].  Col1 fibers can be detected with second 
harmonic generation (SHG) microscopy [1].  SHG microscopy of Col1 fibers detects an intrinsic 
signal derived from the ability of the noncentrosymmetric molecular structure of Col1 fibers to 
give rise to frequency doubling called the second harmonic [1, 7].  Optical imaging such as SHG 
microscopy has limitations of depth penetration, and unless the tissue is superficial or exposed 
for in vivo imaging, or biopsied for ex vivo imaging, optical imaging cannot be used as a 
noninvasive imaging modality.
Diffusion tensor imaging (DTI) has been extensively used to examine tissue 
microstructure and white matter pathology in neurological diseases, as well as for white matter 
tractography [8].  Water molecules predominantly diffuse along neuronal fibers, as diffusion 
across fibers is restricted by axonal membranes and, in the case of myelinated axons, myelin 
sheaths.  Several DTI parameters, e.g. ADC and FA, have been used to visualize fiber tracts and 
quantitatively measure white matter integrity [8].  Analogous to white matter tracts in the brain, 
the extracellular matrix (ECM) of breast cancers contains Col1 fibers that may mediate the 
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patterns of water diffusion in terms of the extent of water diffusion as measured by ADC, the 
degree of anisotropy as measured by FA, and the primary direction of water molecule diffusion 
as measured by the primary eigenvector of estimated diffusion tensor.  It was recently shown that 
DTI was able to detect the Col1 architecture, as validated by SHG microscopy, in the carotid 
artery [9].  These studies identified the potential use of DTI as a noninvasive imaging technique 
to detect and map Col1 fibers [9].  Diffusion MRI is currently being evaluated to detect breast 
cancer, since cancers typically show restricted diffusion [10].  Here we have investigated the 
association between diffusion and anisotropy with breast cancer Col1 fiber distribution, to 
determine if DTI can provide noninvasive imaging indices of Col1 fibers that can be used as 
biomarkers for aggressiveness. 
DTI was combined with SHG microscopy to determine the influence of the Col1 fiber 
density in breast cancer on water diffusion, and to evaluate the potential of diffusion MRI in 
studying Col1 fibers in cancer.  We initially performed a retrospective study of human breast 
cancer samples to determine the correlation between Col1 fibers and water diffusion in these 
samples.  We have previously observed that hypoxic regions, identified by red fluorescence in an 
MDA-MB-231 human breast cancer xenograft model engineered to express red fluorescent
protein under hypoxia, typically contain few Col1 fibers [11].  We therefore characterized 
diffusion in hypoxic and normoxic regions of these tumors in ex vivo studies to further validate 
the relationship between Col1 fibers and diffusion.  We also performed an in vivo – ex vivo DTI 
comparison of these tumors to verify that diffusion patterns observed in vivo spatially matched 
those observed ex vivo.  It was important to establish that patterns observed ex vivo were 
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spatially similar to those observed in vivo, since our ultimate purpose was to determine if DTI 
parameters provided noninvasive indices of Col1 fiber distribution in tumors. 
We found, for the first time, that high Col1 fiber density correlated with increased 
apparent diffusion coefficient (ADC) and fractional anisotropy (FA).  Consistent with our 
previous observations, hypoxic regions contained significantly fewer Col1 fibers [11], and were 
characterized by a lower ADC and FA compared to normoxic tumor regions.  Diffusion patterns 
observed in vivo were spatially similar to those observed ex vivo, suggesting that noninvasive 
DTI can be used to evaluate Col1 fiber density in tumors.  These data also suggest that DTI can 
detect tumor hypoxia through a decrease in Col1 fiber density and highlight the importance of 
Col1 fibers in molecular transport through the ECM.
Methods
An outline of the workflow is summarized in Figure 1.  Three separate studies were 
performed here.  In the first study, we investigated the correlation of water diffusion with Col1 
fiber distribution in surgically resected human breast cancer samples.  To study this, three-
dimensional (3D) high-resolution DTI was performed on these samples (Figure 1, Human 
Sample Ex Vivo Studies).  Following DTI acquisition, the sample was cryosectioned alternately 
at 100 μm and 10 ?m thickness.  Tile scan SHG microscopy to cover the entire tissue section 
was performed to quantify Col1 fibers throughout the 100 μm sections. The 10 ?m sections
were used for histological staining with hematoxylin and eosin (H&E) to identify necrosis.  The 
ADC and FA maps were quantified from DTI.  Col1 fibers were quantified for fiber density as 
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described subsequently in the “SHG and Confocal Microscopy” section.  To correlate water 
diffusion and Col1 fiber distribution, SHG images were co-registered to the corresponding DTI 
sections as described in the “Co-registration Strategy for Ex Vivo and In Vivo Localization 
Quantification” section.  
In the second study, MDA-MB-231 breast cancer xenografts genetically engineered to 
express tdTomato red fluorescent protein under hypoxia (MDA-MB-231-HRE-tdTomato) were 
used to further investigate the relationship between water diffusion and Col1 fibers.  3D high-
resolution DTI was performed on excised breast cancer xenografts (Figure 1, Tumor xenograft ex
vivo studies).  Following DTI, the tumor was sectioned at 1 mm slice thickness using an acrylic 
adjustable tissue slicer (12 mm depth up to 25 mm width; Braintree Scientific, Inc., Braintree, 
MA) and tissue slicer blades (Braintree Scientific, Inc.).  Fluorescence field optical images were 
acquired in the red channel to visualize hypoxic tumor regions.  SHG tile scans were performed 
on these sections to quantify Col1 fibers.  The slices were then given to our pathology laboratory 
for paraffin-embedding and sections were stained with hematoxylin and eosin (H&E).
In the third study, we correlated in vivo DTI data to ex vivo DTI data to validate our ex 
vivo data and evaluate the feasibility of clinically translating this method. In vivo DTI imaging 
was performed on MDA-MB-231-HRE-tdTomato breast cancer xenografts (Figure 1, Breast 
Cancer Xenograft In Vivo Studies).  Following imaging, each tumor was excised and the same 
workflow as described in the second study was followed.  Briefly, the tumor was fixed and ex
vivo 3D high-resolution DT images were acquired, following which the tumor was sectioned at 1 
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mm slice thickness and hypoxic regions identified by optical imaging.  SHG microscopy data 
were acquired to quantify Col1 fibers, and the sections were stained with H&E to mask out 
necrotic areas where present.
Figure 1: Schematic outline of the workflow.  The blue box summarizes the workflow for our ex vivo
study with human breast cancer specimens.  Samples were fixed and 3D DT images were acquired, after 
which the tumor was sectioned alternately at 100 μm thickness and 10 μm thickness to acquire SHG 
microscopic images of the Col1 fiber distribution and for H&E staining, respectively.  For image analysis, 
H&E sections were co-registered to the corresponding SHG images to mask out any necrotic areas, and 
SHG sections were co-registered to the corresponding DTI sections to calculate ADC and FA values.  The 
green box summarizes the workflow for our ex vivo study of breast cancer xenografts.  3D DTI was 
performed on fixed MDA-MB-231-HRE-tdTomato tumors excised from mice, following which tumors 
were sectioned at 1 mm slice thickness to visualize hypoxic regions using optical imaging.  Col1 fiber 
distribution was obtained by SHG microscopy, after which tumor slices were further sectioned to 
prepared H&E stained sections.  For data analysis, H&E sections were co-registered to the corresponding 
SHG images to mask out necrotic regions.  SHG sections were registered to fluorescent images to map 
out hypoxic regions.  Both SHG Col1 and hypoxia images were co-registered to the corresponding DTI 
sections to calculate ADC, FA and Col1 fiber distribution in hypoxic and normoxic tumor regions.  The 
purple block summarizes the workflow for our in vivo study with MDA-MB-231-HRE-tdTomato breast 
cancer xenografts.  DTI acquisitions were done in vivo, following which tumors were excised and fixed in 
4% PFA.  These excised tumors were put through the same experimental and analysis steps as described 
in the workflow for our ex vivo studies in breast cancer xenografts.  Briefly, H&E sections were co-
registered to SHG sections, which were co-registered to hypoxia images and ex vivo DT images, all of 
which were then co-registered to in vivo DT images.  These co-registered in vivo and ex vivo images were 
used to calculate the correlation between in vivo and ex vivo measurements for ADC and FA values.  
Thick arrows indicate the image acquisition workflow, while thin arrows represent the quantification and 
analysis workflow.
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Clinical Specimens
In proof of principle studies, we performed DTI and SHG microscopy on two invasive 
ductal carcinoma (IDC) breast cancer specimens.  One of the tumors was classified as stage IIB 
and the second tumor as stage IIIA.  Both tumors were grade 3, estrogen receptor positive (ER+), 
progesterone receptor positive (PR+), Her2 positive (HER2+), and lymph node positive (LN+).  
Both samples were obtained from Integrated Laboratory Services - Biotech (Chestertown, MD, 
USA).
Breast Cancer Xenografts
The triple-negative metastatic human MDA-MB-231 breast cancer cell line [12] was 
obtained from the American Type Culture Collection (ATCC, Rockville, MD) and maintained as 
previously described [13].  To obtain an optical reporter for hypoxia, MDA-MB-231 cells were 
stably transfected with a construct containing five copies of the hypoxia response element (HRE) 
of the human vascular endothelial growth factor A (VEGF-A) gene ligated to the cDNA of 
tdTomato red fluorescence protein (RFP), which produced MDA-MB-231-HRE-tdTomato cells 
as previously described and validated [14] [Also refer to Thesis Chapter 4].  Before inoculation, 
cells were routinely checked for hypoxia driven tdTomato fluorescence.  Two million MDA-
MB-231-HRE-tdTomato cells were orthotopically inoculated in the right upper thoracic 
mammary fat pad of anesthetized female severe combined immunodeficient (SCID) mice.  
MDA-MB-231-HRE-tdTomato tumor xenografts reached their final experimental size of 
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approximately 500 mm3 within 8 weeks.  Ex vivo studies were performed on 5 tumors and in 
vivo-ex vivo studies were performed on 2 tumors.
SHG and Confocal Microscopy
For the first study, following diffusion imaging, the tumor was cryosectioned alternately 
at 100 μm and 10 μm slice thickness.  Tile scan SHG microscopy was performed to acquire Col1 
fibers from the entire tumor slice on the 100 μm thick section.  For the second and third study, 
tumors were sectioned at 1 mm slice thickness using an acrylic adjustable tissue slicer (12 mm 
depth up to 25 mm width; Braintree Scientific, Inc., Braintree, MA) and tissue slicer blades 
(Braintree Scientific, Inc.). Hypoxic regions were visualized by fluorescence microscopy in 1 
mm thick slices using a 1× objective attached to a Nikon inverted microscope, equipped with a 
Nikon Coolpix digital camera (Nikon Instruments, Inc., Melville, NY).  Bright field images were 
acquired to assess tissue architecture and fluorescence images to detect hypoxic regions, 
followed by tile scan SHG microscopy of the entire slice to acquire Col1 fiber maps.  We used a 
Zeiss 710 NLO Meta confocal microscope (Carl Zeiss Micro-Imaging, Inc.) and an Olympus 
Laser Scanning FV1000 MPE multiphoton microscope (Olympus Corp., US headquarters -
Center Valley, PA) to acquire Col1 fibers in 3D by SHG microscopy.  An incident laser line of 
880 nm/860 nm (Zeiss/Olympus) was used, and the SHG signal from Col1 fibers was detected at 
410-470 nm, as previously described [11, 15] (Chapter 4). On both microscope systems, a 25× 
lens was used to acquire confocal z-stacks with tile scan acquisition performed in x and y 
directions to cover the entire tissue section (339.84 ?m x 339.84 ?m for the Zeiss microscope 
and 390 ?m x 390 ?m for the Olympus microscope), and z-intervals of approximately 5 ?m.  
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Col1 fiber quantification analysis was done in MATLAB R2011b (The MathWorks, 
Natick, MA).  Two major structural characteristics of the Col1 fiber network in the ECM were 
computed using image processing techniques: (i) spatial characteristics were derived using 
Euclidean distance maps to collectively represent the sparseness and density of the distribution 
[11]; (ii) Col1 fiber textural patterns were characterized using texture analysis [16].  For spatial 
characterization, the inter-fiber distance was calculated to account for the empty spaces between 
fibers, and the fiber volume was calculated to assess fiber density [11].  Textural characteristics 
were computed by a statistics based texture analysis method that calculates the two-dimensional 
(2D) histogram of the image referred to as the co-occurrence matrix [16].  Haralick texture 
features were extracted from the resulting co-occurrence matrix [17].  Haralick texture features 
extract fibers and evaluate the spatial inter-relations of these fibers that vary across the tissue 
from straight and aligned fibers to wavy and crisscrossing fibers, which are described by 13 
Haralick features [17].  The texture features entropy, energy, variance, maximum probability and 
inverse variance were able to distinguish between the different Col1 fiber patterns and gave a 
heterogeneous map matching the heterogeneous fiber patterns observed.  Only these features 
were then used for further processing.  By using fuzzy C-mean clustering [18], Haralick texture 
features were clustered and color-coded in 3D projected SHG images to represent the 3D fiber 
information in 2D. 
Following SHG image acquisition, sections were given to our pathology laboratory for 
paraffin-?????????? ???? ??????????? ????? ?? ?????????? ??? ?? ??? ?????????? ????
immunohistochemistry.  These sections were stained with H&E.
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Ex Vivo DTI Acquisition
The samples (human specimens, N=2, and excised xenograft tumors, N=7) were fixed for 
24 hours in 4% paraformaldehyde, and washed with phosphate buffered saline for 72 h.  The 
samples were spatially marked and placed in a 10 mm NMR tube immersed in Fomblin perfluoro 
polyether solution (Solvay Sollexis).  MRI was performed on a Bruker Avance NMR 
spectrometer (Bruker Biospin, Billerica, MA, USA) equipped with a vertical 11.7 Tesla magnet 
and micro-imaging accessories.  A Micro 2.5 gradient set capable of maximum 1500 mT/m 
gradient strength with a 10 mm birdcage volume coil was used.  High-resolution T2- weighted 
MRI, and DTI of the sample were performed in three dimensions (3D) with an isotropic 
resolution of 62.5 x 62.5 x 62.5 ?m3. DTI was performed using a modified 3D diffusion-
weighted gradient and spin echo (DW-GRASE) sequence [19] with the following parameters: 
TE/TR = 36/1500 ms, 4 signal averages, two non-diffusion weighted images and six diffusion 
directions, b=1500 s/mm2, field of view (FOV) = 8 mm x 8 mm x 9 mm, a matrix size of 128 x 
128 x 150, and.  From these images, the average diffusion-weighted (aDW) images and maps of 
apparent diffusion coefficient (ADC) and fractional anisotropy (FA) were calculated using DTI 
Studio image processing software [20].
In Vivo DTI Acquisition
To validate our ex vivo observations of water diffusion, we performed in vivo DTI on 
MDA-MB-231-5HRE-TdTomato breast cancer xenografts as described above.  A horizontal 
11.7T Bruker system (Bruker Corp., Billerica, MA, USA) was used to acquire the DTI with a 10 
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mm diameter solenoid coil.  High-resolution T2-weighted anatomical images of the tumor were 
acquired followed by diffusion-weighted images.  Coronal sections were acquired as shown in 
Figure 1, (Tumor Xenograft In Vivo Studies).  Mice were anesthetized with isoflurane (1%) in air 
and oxygen mixed at 3:1 ratio via vaporizer and positioned in an animal holder (Bruker BioSpin, 
Billerica, MA, USA).  Respiration was monitored via pressure sensor (SAII, Stony Brook, NY, 
USA) and maintained at 40–60 breaths per minute.  T2-weighted images were acquired using a 
RARE sequence with imaging parameters of TE/TR = 12.31/3000 ms, 8 averages, FOV = 14 
mm x 10 mm, and matrix of 192 by 144 with 20 z-slices of 0.4 mm thickness.  For the same 
FOV, diffusion-weighted images were acquired using a modified EPI sequence with imaging 
parameters of TE/TR = 23.6/5000 ms, 2 repetitions, 5 non-diffusion weighted and 30 diffusion 
directions, b-value ~1500 s/mm2, FOV = 14 mm x 10 mm, matrix size of 128 x 96, native 
imaging resolution = 0.105 mm x 0.105 mm, and 20 z-slices.  Similar to ex vivo DTI image 
quantification, aDW, ADC, and FA maps were calculated for in vivo DTI images using DTI 
Studio software [20].
Co-registration Strategy for Ex Vivo and In Vivo Localization Quantification
For localization and correlation quantification of Col1 fibers, hypoxia and water 
diffusion, affine transformation based co-registration was performed as previously described [21]
(Chapter 4).  For the third study, ex vivo DT images were first co-registered to corresponding in 
vivo DTI data.  After this, and similar to the second study, optical hypoxia images were co-
registered to the registered ex vivo DTI data.  In both second and third studies, SHG images were 
co-registered to the registered hypoxia images.  For the first study, SHG images were co-
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registered to the corresponding ex vivo DTI images for localization quantification.  After every 
step of co-registration the Dice similarity index [22] was calculated to evaluate the co-
registration error.  For multimodal data of ex vivo DTI registered to in vivo DTI, and ex vivo
optical data registered to ex vivo registered DTI, a Dice similarity index > 0.85 was considered as
a successful co-registration.
For the first study, we used a previously developed technique [23], where the histology
image was used to predict the FA map.  Here we used our SHG Col1 fiber distribution image to 
predict the water diffusion image.  Briefly, we initially performed turkey window filtering and 
zero mean normalizing to the image to avoid edge and central spike effects, after which 2D fast 
Fourier transform was applied and a radial histogram was calculated from the resulting image, 
followed by principle component analysis to calculate anisotropy and primary orientation [23].
The predicted diffusion and water diffusion direction maps were compared to the DTI ADC, FA 
and color-coded water direction maps.  This code was written in MATLAB and was developed 
and validated in Dr. Jiangyang Zhang’s laboratory.  Additionally, in the first study, ADC and FA 
values were calculated in masks of four segmented categories in the SHG images for density and 
sparseness and masks of three segmented categories for textural patterns.  Fiber density and 
sparseness were classified into masks of dense fiber regions (75% < percent fiber volume, inter-
fiber distance < 1 ?m), intermediate-1 fiber regions (50% < percent fiber volume < 75%, 2 ?m < 
inter-fiber distance < 5 ?m), intermediate-2 fiber regions (25% < percent fiber volume < 50%, 2 
?m < inter-fiber distance < 5 ?m) and sparse fiber regions (percent fiber volume < 25%, 5 ?m <
inter-fiber distance).  The ADC and FA values were calculated in 10 equidistantly spaced regions 
of interests (ROIs) for each mask from each tumor.  A two-sided t-????????????????????????????
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detect significant differences between ADC and FA values in the dense, intermediate-1,
intermediate-2 and sparse fiber regions using Microsoft Office Excel 2007 (Microsoft, Redmond, 
WA). Similarly, three masks were segmented by fuzzy c-mean clustering [24, 25] from the 
combined Haralick texture feature maps into straight fibers, fibers of mixed patterns, and fibers 
of wavy pattern.  ADC and FA values were calculated in 10 equidistantly spaced ROIs for each 
mask from each tumor.  A two-sided t-???????????????????????????????????????????????????????????
between ADC and FA values for the straight, mixed and wavy Col1 fiber patterns using 
Microsoft Office Excel 2007 (Microsoft, Redmond, WA).  P values < .05 were considered to be 
significant.
In the second study, hypoxic regions were drawn out from co-registered optical bright field and 
fluorescence images.  ADC and FA values were calculated in normoxic and hypoxic regions and 
compared for all mice (N=5).  Percent fiber volume and inter-fiber distances were also calculated 
for hypoxic and normoxic regions.  A two-sided t-??????????0.05) was used to detect significant 
differences between hypoxic and normoxic ROIs for ADC, FA and Col1 fiber quantification 
using Microsoft Office Excel 2007 (Microsoft, Redmond, WA).  P values < .05 were considered 
to be significant.
In the third study, in vivo DTI data were correlated with ex vivo DTI data.  Pearson’s 
correlation coefficient was calculated for in vivo and ex vivo ADC and FA maps for four slices 
from each tumor.  In addition, ADC, FA and Col1 fibers were quantified in normoxic versus
hypoxic regions as described for the second study.  A one-sided t-????? ???????????????????? ???
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detect significant differences between hypoxic and normoxic ROIs using Microsoft Office Excel 
2007 (Microsoft, Redmond, WA). P values < .05 were considered to be significant. 
For all the studies, H&E sections from the imaged slices were co-registered to 
corresponding DTI images using affine transformation as described above.  These co-registered 
H&E sections were used to detect necrotic regions.  Necrotic regions, if present, were eliminated 
from quantification analysis.
Results
Human Sample Ex Vivo Studies
We observed distinct heterogeneities in the diffusion images of human breast cancer 
samples as apparent in the representative images shown in Figure 2.  Displayed in Figure 2A-D
are aDW image, ADC map, FA map, and the color-coded water diffusion directionality map, 
respectively.  The corresponding H&E stained histological section is shown in Figure 2E.  Col1 
fiber images acquired using SHG microscopy of the DT imaged slices displayed a similar 
distinct pattern as observed in the diffusion tensor images (Figure 2F).  We simulated water 
diffusion and water diffusion directionality maps from the SHG data.  The simulated results 
displayed in Figure 2G-H closely matched the actual ADC, FA and water diffusion directionality 
maps.  
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To characterize the Col1 fiber patterns, texture analyses of the SHG images were 
performed, and Haralick texture features were calculated.  Using fuzzy c-mean clustering, 
Haralick texture features were clustered to color-code 2D projected SHG images with 3D fiber 
pattern information.  This texture feature clustering was able to distinguish Col1 fiber patterns 
into three characteristic categories, which were straight fiber pattern, mixed patterns and wavy 
texture pattern (Figure 2I).  An overlay of the ADC map (gray) with the SHG image (red) is 
displayed in Figure 2J, an overlay of the FA map (gray) with the SHG image (red) is displayed in 
Figure 2K, and an overlay of the FA map (gray) with the simulated diffusion map (red) is 
displayed in Figure 2L.  These overlay images identified a close association between Col1 fibers 
and water diffusion and anisotropy.
Analysis of 10 ROIs for fiber content quantification and fiber distribution quantification 
are presented in Figure 3 for one of the tumors.  We observed that regions with sparse fibers had 
significantly reduced ADC values (p-value < 0.01, N = 10) as compared to regions containing 
dense, intermediate-1 or intermediate-2 fiber content (Figure 3A).  Fractional anisotropy values 
were significantly reduced (p-value < 0.01, N = 10) in regions with sparse fibers as compared to 
regions with dense, intermediate-1 or intermediate-2 Col1 fiber content (Figure 3B).  The four
fiber content masks of dense fibers regions (red), intermediate-1 fiber content (gray),
intermediate-2 fiber content (green) and sparse Col1 fiber regions (blue) are shown in Figure 3C.  
Within the constraints of our texture analysis approach, we did not observe any differences in 
ADC or FA values for straight, mixed and wavy fiber patterns (Figure 3D-E, p-value > 0.05, N = 
10).  Texture analysis masks of straight (red), mixed (green) and wavy (blue) Col1 fiber patterns 
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are shown in Figure 3F. Similar differences were observed for both tumors but data from only 
one tumor are presented.
Figure 2:  Representative images of a human breast cancer specimen.  (A) A representative aDW image, 
(B) corresponding ADC map, (C) corresponding FA map, (D) corresponding water diffusion direction 
color map, (E) corresponding H&E section, (F) corresponding SHG map of Col1 fiber distribution.  (G) 
Water diffusion and (H) water diffusion directionality simulated from SHG Col1 fiber images.  (I) Color-
coded SHG image for straight, mixed and wavy fiber patterns based on texture analysis, (J) overlay of 
ADC map (gray) and SHG image (red), (K) overlay of FA map (gray) and SHG image (red), and (L) 
overlay of measured FA map (gray) and simulated diffusion map (red).  Scale bar of 2 mm for all images 
(A-L).
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Figure 3: Quantification of DTI and Col1 data obtained from a representative human breast cancer 
specimen.  Significantly reduced (A) ADC values and (B) FA values were observed in regions that 
contained sparse Col1 fibers as compared to regions with dense, intermediate-1 or intermediate-2 Col1 
fiber content (p-value < 0.01, N = 10).  (C) Fiber content masks of dense (red), intermediate-1 (gray), 
intermediate-2 (green) and sparse fibers (blue).  No differences in ADC and FA values were observed in 
the texture analysis shown in (D) and (E), respectively (p-value > 0.05, N = 10).  (F) Texture analysis 
masks of straight (red), mixed (green) and wavy fibers (blue).
Breast Cancer Xenograft Ex Vivo Studies
To further investigate the correlation between water diffusion and Col1 fibers, and the 
influence of hypoxia on water diffusion, we performed additional studies in MDA-MB-231 
breast cancer xenografts genetically engineered to express tdTomato red fluorescent protein 
under hypoxia.  Representative images of ex vivo tumors are shown in Figure 4.  Displayed in 
Figure 4A-D are aDW image, ADC map, FA map, and water diffusion directionality map, 
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respectively.  The corresponding optical image showing hypoxic fluorescing regions in red is 
displayed in Figure 4E.  Overlay images of ADC map (gray) and hypoxia (red), FA map (gray) 
and hypoxia (red), and SHG image (gray) and hypoxia (red) are displayed in Figure 4F-H, 
respectively, and demonstrate that hypoxic regions had lower ADC and FA values compared to 
normoxic regions.  The H&E section obtained from the corresponding slice is shown in Figure 
4I, and demonstrates that high ADC values were observed in frankly necrotic regions.  These 
necrotic regions were eliminated from all analyses.  
Figure 4: Ex vivo images from breast cancer xenografts.  Representative corresponding (A) aDW image, 
(B) ADC map, (C) FA map, and (D) water diffusion directionality color map.  (E) Corresponding optical 
image displaying hypoxic red fluorescing regions (red).  (F-H) Overlay images of hypoxia (red) with 
ADC map (gray), FA map (gray), or SHG image (gray), respectively.  (I) Corresponding H&E stained 
section.
Quantified data summarized for five tumors are shown in Figure 5.  Hypoxic regions had 
significantly lower percent Col1 fiber volume as compared to normoxic regions (Figure 5A, p-
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value = 0.0383, N = 3).  Similar to our observation in human breast cancer specimens, these 
breast tumor models showed again that low Col1 containing hypoxic areas had a significantly 
lower ADC value (Figure 5B, p-value = 0.0592, N = 5) and FA value (Figure 5C, p-value = 
0.0308, N = 5) compared to normoxic regions.
Figure 5: Quantification of DTI and hypoxia data obtained from breast cancer xenografts ex vivo.  (A) 
Percent fiber volume was significantly lower in hypoxic regions as compared to normoxic regions (p-
value = 0.0383, N = 3).  Significantly lower (B) ADC and (C) FA values were observed in hypoxic 
regions as compared to normoxic regions (p-value = 0.0592 and p-value = 0.0308, respectively, N = 5).
Breast Cancer Xenograft In Vivo-Ex Vivo Studies
Representative images of a comparison between in vivo and ex vivo DTI data from the 
same tumor are shown in Figure 6.  A good spatial co-localization of ADC and FA features 
between in vivo and ex vivo images is evident from these representative images (Figure 6A-H).  
Comparisons were made for aDW images in vivo and ex vivo in Figure 6A, E, respectively, ADC 
maps in vivo and ex vivo in Figure 6B, F, respectively, FA maps in vivo and ex vivo in Figure 6C, 
G, respectively, and water diffusion directionality in vivo and ex vivo in Figure 6D, H, 
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respectively.  The corresponding optical red fluorescence image and the H&E stained 
histological section are displayed in Figures 6I and J, respectively. Confirming our earlier data 
[11], we observed a reduction of Col1 fibers in hypoxic tumor regions as shown in Figures 6K-L.  
Overlay images of hypoxia (red) with in vivo ADC (gray) and FA (gray) maps and ex vivo ADC 
(gray) and FA (gray) maps are shown in Figures 6M-P, respectively.  
Figure 6: Comparison between in vivo and ex vivo DTI data in breast cancer xenografts.  (A-D) 
Representative in vivo DT images of (A) aDW image, (B) ADC map, (C) FA map, and (D) water 
diffusion directionality color map.  Corresponding ex vivo DT images of (E) aDW image, (F) ADC map, 
(G) FA map, and (H) water diffusion directionality color map.  Ex vivo optical images of (I) hypoxic 
fluorescing regions, (J) H&E, (K) SHG Col1 fibers, and (L) overlay of SHG Col1 fibers with hypoxic 
regions.  (M-P) Overlay of hypoxic regions (red) with (M) in vivo ADC map (gray), (N) in vivo FA map 
(gray), (O) ex vivo ADC map (gray), and (P) ex vivo FA map (gray).
Quantification of data from four slices obtained from two tumors are summarized in Figure 7 A-
D.  A strong correlation (Co-relation coefficient = 0.80) was observed between spatially co-
localized in vivo and ex vivo ADC maps as shown in Figure 7A.  Similarly, a good correlation 
(Co-relation coefficient = 0.56) was observed between spatially co-localized in vivo and ex vivo
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FA maps as shown in Figure 7B.  Significantly lower ADC values were observed in hypoxic 
regions as compared to normoxic regions for both in vivo and ex vivo data (Figure 7C, p-value < 
0.05, N = 4).  Also, significantly lower FA values were observed in hypoxic regions as compared 
to normoxic regions for both in vivo and ex vivo data (Figure 7D, p-value < 0.04, N = 4).  The 
analysis was performed using a paired t-test on four slices per tumor.  Significant differences 
were observed for both tumors but data from only one tumor are presented.
Figure 7: Quantification of in vivo and ex vivo DTI data comparison in breast cancer xenografts.  (A) 
Correlation between spatially co-localized in vivo and ex vivo ADC maps.  (B) Correlation between in 
vivo and ex vivo FA maps.  Correlations are a composite from all images acquired from two tumors.  (C) 
ADC (p-value < 0.05, N = 4) and (D) FA (p-value < 0.04, N = 4) values were significantly decreased in 
hypoxic versus normoxic regions quantified from both in vivo and ex vivo DTI data.   Statistical analysis 
was performed using a paired t-test on four slices per tumor.  Significant differences were observed for 
both tumors but data from only one tumor is presented.
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Discussion
Here we have demonstrated for the first time that Col1 fibers participate in mediating 
water diffusion and anisotropy.  Data obtained from human breast cancers demonstrated that 
regions with high Col1 fiber content showed significantly increased ADC and FA values, as 
evident from our fiber content quantification analysis.  Within the constraints of our texture 
analysis approach, we did not detect an influence of fiber textures on ADC and FA values, 
suggesting that fiber content rather than fiber texture mediates water diffusion.  These data 
suggest that ADC and FA maps may provide noninvasive biomarkers of Col1 fiber density.  
Ex vivo studies of human breast cancer xenografts further confirmed our observations 
made in human breast cancer specimens.  In this tumor model, hypoxic low Col1 fiber 
containing regions showed decreased ADC and FA values compared to normoxic regions that 
had significantly higher percent fiber volume, which was comparable to our findings in human 
breast cancers in terms of Col1 fiber content. In vivo studies in tumor xenografts demonstrated a 
good agreement of ADC and FA patterns between in vivo and ex vivo images, supporting that 
conclusions drawn from ex vivo measurements of Col1 fibers, ADC and FA are likely to hold in 
corresponding in vivo measurements.  These data also have implication for noninvasive detection 
of hypoxic regions, which could be deduced from ADC and FA maps obtained in vivo, as well as 
for the delivery of low molecular weight agents with similar polarity and charge as water, which 
would likely display diffusive patterns that resemble those of water as detected in ADC and FA 
maps.
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Our finding that Col1 fiber density positively correlated with ADC values suggests that 
Col1 fibers enhance water diffusion in malignant breast cancers that are characterized by high 
Col1 fiber content [15]. In areas of dense Col1 fibers, we observed an increased fractional 
anisotropy as detected by DTI.  This is in good agreement with two recent DTI studies of human 
articular cartilage [26], and porcine carotid artery [9], in which the directionality of water 
diffusion was consistent with the zonal distribution of Col1 fiber orientation.  It has been shown 
that fiber network alignment does not affect the overall diffusion coefficient [27], but only 
affected diffusion anisotropy.  This could be one reason why we did not observe differences in 
ADC values in different fiber texture patterns. 
Recent clinical in vivo studies demonstrated that the ADC in breast cancers was 
significantly lower than that of benign breast lesions and normal breast tissue [10, 28], and is 
accompanied by decreased FA in cancer versus normal tissue [28].  A decrease in the ADC and 
FA values observed in breast cancer could be due to the presence of hypoxic regions within the 
tumor, in which Col1 fiber content is significantly lower as previously shown [11].  Our findings 
suggest that averaging the ADC and FA values in a breast lesion may not provide an accurate 
assessment for characterizing breast tumors, as information on spatial heterogeneity within the 
tumor is lost [29].
The results obtained here strongly encourage further investigation of using ADC and FA 
to noninvasively image Col1 fiber density as well as hypoxia.  Additionally, these data extend 
our earlier studies, which demonstrated that Col1 fibers facilitate macromolecular transport 
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(Chapter 4) [30].  The results obtained here suggest that transport through the ECM of low 
molecular weight agents with comparable charge and polarity to water is also mediated by Col1 
fibers, with implications for the delivery and transport of low molecular weight chemotherapy 
agents through the ECM.  These results indicate that diffusion MRI may be used to assess Col1 
fiber density in breast lesions, which is useful because high Col1 fiber density is a hallmark of 
malignant breast cancers and can facilitate metastatic dissemination from the primary lesion 
along Col1 fibers [2].
In conclusion, we have shown that dense and intermediate Col1 fibers in breast cancers 
can enhance water diffusion and increase diffusion anisotropy.  Noninvasive DTI may be used as 
a surrogate marker to assess Col1 fiber density in breast cancers, which is important because 
high Col1 fiber density is associated with mammary tumor initiation, progression and metastasis 
[2].  A decrease in ADC and FA values observed within a lesion could be predictive of hypoxic 
regions and may contribute to better patient management.  Future studies should focus on the 
dynamic range of ADC and FA that can quantitatively predict Col1 fiber density differences that 
influence breast cancer progression and metastasis.
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